inside this issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1....

66
Highlights of Changes This Week at ClinicalTrials.gov: New Sponsors: Fourteen sponsors registered studies at ClinicalTrials. gov for the first time this week. Those sponsors are Akron Molecules, Atopix Therapeutics, Beijing Minhai Biotechnology, Citrus Valley Med- ical Research, Cotera, Great Lakes NeuroTechnologies, Great Lakes Pharmaceuticals, Labrys Biologics, Leaf Healthcare, Maco Productions, Ortek Therapeutics, SciVision Biotech, Stada Arzneimittel and Visior Technologies. For more details, see New Sponsors on Page 2. New Studies: One hundred and forty-six new studies were registered this week, including studies sponsored by Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Genzyme, GlaxoSmithKline, Hoffmann-La Roche, Merck, Novartis, Pfizer, St. Jude Medical, Takeda and Vanda. For more details, see New Studies on Page 3 . New Results: Fifty industry-sponsored studies posted results this week, including studies by AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Novartis, Pfizer, St. Jude Medi- cal and UCB. For more details, see New Results on Page 8. New Study Status: One hundred and eighty-eight studies are reporting changes in their status as planning, recruiting, ongoing or completed this week. Among the sponsors are Allergan, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, GlaxoSmithKline, Hoffmann- La Roche, Janssen, Medtronic, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi and Vertex. For more details, see New Study Status on Page 10 . Vol. 2, No. 50 Dec. 12, 2013 New Sponsors .......... Page 2 New Studies ............. Page 3 New Results ............. Page 8 New Study Status...Page 10 Studies Opening a First Site in a New Country ...Page 17 Studies Opening Additional Sites in a Country ..Page 31 Study Sites by Country .................. Page 55 Studies Under Planning ................. Page 56 Studies Ended or Halted..................... Page 66 INSIDE THIS ISSUE SUMMARY OF LATEST TRIAL UPDATES Week Ending Dec. 12 Dec. 5 Nov. 28 Nov. 21 Total New Sponsors 14 6 15 21 56 New Studies 146 113 280 144 683 New Results 50 41 84 45 220 New Study Status 188 183 156 211 738 Studies Opening a First Site in a New Country 374 238 269 304 1,185 Studies Opening Additional Sites in a Country 630 452 495 558 2,135 Studies Under Planning 285 287 288 279 1,139 Studies Ended or Halted 12 9 19 25 65 (See Highlights, Page 2)

Upload: others

Post on 10-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

Highlights of Changes This Week at ClinicalTrials.gov:New Sponsors: Fourteen sponsors registered studies at ClinicalTrials.gov for the first time this week. Those sponsors are Akron Molecules, Atopix Therapeutics, Beijing Minhai Biotechnology, Citrus Valley Med-ical Research, Cotera, Great Lakes NeuroTechnologies, Great Lakes Pharmaceuticals, Labrys Biologics, Leaf Healthcare, Maco Productions, Ortek Therapeutics, SciVision Biotech, Stada Arzneimittel and Visior Technologies. For more details, see New Sponsors on Page 2.

New Studies: One hundred and forty-six new studies were registered this week, including studies sponsored by Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Genzyme, GlaxoSmithKline, Hoffmann-La Roche, Merck, Novartis, Pfizer, St. Jude Medical, Takeda and Vanda. For more details, see New Studies on Page 3.

New Results: Fifty industry-sponsored studies posted results this week, including studies by AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Novartis, Pfizer, St. Jude Medi-cal and UCB. For more details, see New Results on Page 8.

New Study Status: One hundred and eighty-eight studies are reporting changes in their status as planning, recruiting, ongoing or completed this week. Among the sponsors are Allergan, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, GlaxoSmithKline, Hoffmann-La Roche, Janssen, Medtronic, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi and Vertex. For more details, see New Study Status on Page 10.

Vol. 2, No. 50Dec. 12, 2013

New Sponsors ..........Page 2

New Studies .............Page 3

New Results .............Page 8

New Study Status ...Page 10

Studies Opening a First Site in a New Country ...Page 17

Studies Opening Additional Sites in a Country ..Page 31

Study Sites by Country ..................Page 55

Studies Under Planning .................Page 56

Studies Ended or Halted .....................Page 66

INsIde thIs Issue

Summary of laTeST Trial upDaTeS

Week ending Dec. 12 Dec. 5 Nov. 28 Nov. 21 Total

New Sponsors 14 6 15 21 56New Studies 146 113 280 144 683New Results 50 41 84 45 220New Study Status 188 183 156 211 738Studies Opening a First Site in a New Country 374 238 269 304 1,185Studies Opening Additional Sites in a Country 630 452 495 558 2,135Studies Under Planning 285 287 288 279 1,139Studies Ended or Halted 12 9 19 25 65

(See Highlights, Page 2)

Page 2: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 2

Studies Opening a First Site in a New Country: Three hundred and seventy-four new study sites launched this week in countries where the sponsors did not have study sites. For more details, see Studies Opening a First Site in a New Country on Page 17.

Studies Opening Additional Sites in a Country: Six hundred and thirty new study sites launched this week in countries where the sponsors already had study sites. For more details, see Studies Opening Addi-tional Sites in a Country on Page 31.

Study Sites by Country: A handy table that lists all countries with first-time and additional study sites that launched this week can be found at Study Sites by Country on Page 55.

Studies Under Planning: About 10% of the studies listed as in the planning stage are replaced each week. This week’s 285 listings include planned studies at Abbott, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Hoffmann-La Roche, Janssen, Merck, Millennium, Novartis, Pfizer, Sanofi, St. Jude Medical, Takeda and UCB. For more details, see Studies Under Planning on Page 56.

Studies Ended or Halted: Twelve studies were terminated, suspended or withdrawn this week, including studies sponsored by Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche and Merck. For more details, see Studies Ended or Halted on Page 66.

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX

aGeDiSeaSe/

CoNDiTioN

NCT02006121 STADA DRUG 1. PLANNING 3 10230

YEARS N/A NEUR PARKINSON

NCT02005692 LEAF HEALTHCARE

DEVICE 1. PLANNING NA 7018

YEARS N/A

DERM WOUND/ ULCER

NCT02006173 SCIVISION DRUG 1. PLANNING NA 4030

YEARS 60

YEARS DERM NASOLABIAL FOLDS

NCT01991509 LABRYS BIOLOGICS

BIOLOGICAL 2. RECRUITING 1 3618

YEARS 60

YEARS HEALTHY/PHARM

NCT02003118 AKRON DRUG 2. RECRUITING 2 26040

YEARS 75

YEARS RHEUM ARTHRITIS/GOUT

NCT02002208 ATOPIX DRUG 2. RECRUITING 2 20018

YEARS 40

YEARS ALLERGY ECZEMA/DERMATITIS

NCT02003495 BEIJING MINHAI

BIOLOGICAL 2. RECRUITING 3 2,1952

MONTHS 6 YEARS INFECT MENINGITIS

NCT01989091 GREAT LAKES PHARM.

DEVICE 2. RECRUITING 3 30018

YEARS 85

YEARS UROLOGY KIDNEY FAILURE

NCT02002637 COTERA DEVICE 2. RECRUITING NA MISS-ING

30 YEARS

65 YEARS

RHEUM ARTHRITIS/GOUT

NCT01978080 GREAT LAKES NEURO.

DEVICE 2. RECRUITING NA 40 N/A N/A NEUR TREMOR

NCT02007473 MACO 2. RECRUITING NA 80 N/A N/A HEALTHY/PHARM

NCT02003235 VISIOR DEVICE 2. RECRUITING NA 12 5 YEARS 8 YEARS OPHTHAL EYE DISEASE

Highlights, from Page 1

NeW SpoNSorS

This table lists new sponsors that have never previously registered studies at ClinicalTrials.gov.

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Sponsors, Page 3)(Return to Page 1)

Page 3: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 3

NeW STuDieS

This table lists every new study registered in the past week.

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioNNCT02000362 KANG STEM BIOLOGICAL 1. PLANNING 1 30 20 YEARS 70 YEARS GI CROHN

NCT02000453 GSK DRUG 1. PLANNING 1 1518

YEARS 75

YEARS GI ULCERATIVE COLITIS

NCT02000700 JANSSEN DRUG 1. PLANNING 1 16 10 YEARS 17 YEARS ENDO DIABETES

NCT02001623 GENMAB DRUG 1. PLANNING 1 54 18 YEARS N/A ONC O&G: OVARY

NCT02001909 BAYER DRUG 1. PLANNING 1 3618

YEARS 45

YEARS ONC SOLID TUMOR/CANCER

NCT02002611 CHONG KUN DANG

DRUG 1. PLANNING 1 2419

YEARS 55

YEARS ENDO DIABETES

NCT02002767 GILEAD DRUG 1. PLANNING 1 2018

YEARS 79

YEARS INFECT HEPATITIS C

NCT02003573 BOEHRINGER INGELHEIM

DRUG 1. PLANNING 1 13660

YEARS N/A

ONC HEM: LEUKEMIA

NCT02004106 HOFFMANN-LA ROCHE

DRUG 1. PLANNING 1 11018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02004132 ELI LILLY DRUG 1. PLANNING 1 12 18 YEARS N/A HEALTHY/PHARM

NCT02004301 BIO-IMAGES DRUG 1. PLANNING 1 1218

YEARS 45

YEARS RHEUM ARTHRITIS/GOUT

NCT02004327 DONG WHA DRUG 1. PLANNING 1 6 20 YEARS 55 YEARS ENDO DIABETES

NCT02005211 ASTRAZENECA DRUG 1. PLANNING 1 40 20 YEARS 80 YEARS HEALTHY/PHARM

NCT02005744 CHONG KUN DANG

DRUG 1. PLANNING 1 2419

YEARS 64

YEARS GI LIVER FAILURE

NCT02006147 TAIWAN LIPOSOME

DRUG 1. PLANNING 1 3020

YEARS N/A

OPHTHAL MACULAR EDEMA

NCT02006290 PFIZER DRUG 1. PLANNING 1 18 30 YEARS 70 YEARS NEUR PARKINSON

NCT02006537 GSK DRUG 1. PLANNING 1 28 18 YEARS N/A RESP COPD

NCT02006589 GSK DRUG 1. PLANNING 1 1618

YEARS 65

YEARS CARDIO HYPERTENSION

NCT02006602 GSK DRUG 1. PLANNING 1 1618

YEARS 65

YEARS CARDIO HYPERTENSION

NCT02007070 MERCK BIOLOGICAL 1. PLANNING 1 24 20 YEARS N/A ONC RESP: LUNG

NCT02000219 OXTHERA BIOLOGICAL 1. PLANNING 2 8 N/A N/A UROLOGY KIDNEY DISEASE

NCT02000427 AMGEN DRUG 1. PLANNING 2 4118

YEARS N/A

ONC HEM: LEUKEMIA

NCT02000440 GSK DRUG 1. PLANNING 2 2418

YEARS 65

YEARS UROLOGY KID-NEY NEPHRITIS

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Studies, Page 4)(Return to Page 1)

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX

aGeDiSeaSe/

CoNDiTioN

NCT02000401 CITRUS VALLEY

DRUG 4. COMPLETED 4 1518

YEARS 64

YEARS INFECT CYSTITIS

NCT02002728 ORTEK 4. COMPLETED NA 200 6 YEARS 9 YEARS DENTAL CARIES

New Sponsors, from Page 2

Page 4: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 4

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioNNCT02000609 CHIESI DRUG 1. PLANNING 2 45 40 YEARS 75 YEARS RESP COPD

NCT02000817 GSK BIOLOGICAL 1. PLANNING 2 40 16 YEARS 27 YEARS ENDO DIABETES

NCT02000882 US ONCOLOGY DRUG 1. PLANNING 2 40 18 YEARS N/A ONC BREAST

NCT02001181 PFIZER DRUG 1. PLANNING 2 7018

YEARS 50

YEARS ALLERGY ECZE-MA/DERMATITIS

NCT02001688 KAMADA BIOLOGICAL 1. PLANNING 2 4018

YEARS 65

YEARS ENDO ALPHA 1-ANTITRYPSIN

NCT02002689 NOVARTIS DRUG 1. PLANNING 2 7018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02002702 NOVARTIS DRUG 1. PLANNING 2 4520

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT02004262 ADURO BIOLOGICAL 1. PLANNING 2 24018

YEARS N/A

ONC GI: PANCREAS

NCT02004288 BIOGAIA DIETARY SUP.

1. PLANNING 2 30 8 YEARS 18

YEARS PSYCH ANOREXIA

NCT02004691 GENZYME DRUG 1. PLANNING 2 15 18 YEARS N/A ENDO LIPIDOSIS

NCT02005523 REVALESIO DRUG 1. PLANNING 2 2418

YEARS 50

YEARS ORTH JOINT DISEASE

NCT02005848 KAMADA BIOLOGICAL 1. PLANNING 2 192 8 YEARS 25 YEARS ENDO DIABETES

NCT02006472 TEVA DRUG 1. PLANNING 2 40021

YEARS N/A

NEUR HUNTING-TON/DYSTONIA

NCT02006628 GW DRUG 1. PLANNING 2 7818

YEARS 65

YEARS PSYCH SCHIZOPHRENIA

NCT02007252 NOVARTIS DRUG 1. PLANNING 2 10045

YEARS N/A

CARDIO ANEURYSM

NCT02000622 ASTRAZENECA DRUG 1. PLANNING 3 31018

YEARS N/A ONC BREAST

NCT02001987 HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 13018

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT02002884 MERZ DRUG 1. PLANNING 3 344 2 YEARS 17

YEARS NEUR SPASTIC-ITY/PALSY

NCT02003144 ALEXION BIOLOGICAL 1. PLANNING 3 13218

YEARS N/A

OPHTHAL OPTIC NERV DISEASE

NCT02004392 ENVIVO DRUG 1. PLANNING 3 1,00055

YEARS 85

YEARS NEUR ALZHEIMER/DEMENT

NCT02004626 CRISTALIA DRUG 1. PLANNING 3 9218

YEARS 80

YEARS DERM WOUND/ULCER

NCT02005471 HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02006121 STADA DRUG 1. PLANNING 3 10230

YEARS N/A NEUR PARKINSON

NCT02006641 H LUNDBECK DRUG 1. PLANNING 3 84050

YEARS N/A

NEUR ALZHEIMER/DEMENT

NCT02006654 H LUNDBECK DRUG 1. PLANNING 3 72050

YEARS N/A

NEUR ALZHEIMER/DEMENT

NCT02006888 ICON DRUG 1. PLANNING 3 35240

YEARS N/A

RHEUM INFLAMMATION

New Studies, from Page 3

(See New Studies, Page 5)(Return to Page 1)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

Page 5: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 5

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT02000531 HOFFMANN-LA ROCHE

DRUG 1. PLANNING 4 14018

YEARS N/A ONC RESP: LUNG

NCT02002221 NOVARTIS DRUG 1. PLANNING 4 152 20 YEARS 74 YEARS ENDO DIABETES

NCT02003391 ALCON DRUG 1. PLANNING 4 15618

YEARS N/A

OPHTHAL GLAUCOMA

NCT02006693 AQUESYS DEVICE 1. PLANNING 4 20018

YEARS N/A

OPHTHAL GLAUCOMA

NCT02007278 NOVARTIS DRUG 1. PLANNING 4 40 18 YEARS N/A ENDO DIABETES

NCT01726257 ENDOLOGIX DEVICE 1. PLANNING NA 18018

YEARS N/A

CARDIO ANEURYSM

NCT02000466 GSK OTHER 1. PLANNING NA 112

YEARS 64

YEARS INFECT INFLUENZA/FLU

NCT02001545 ASTRAZENECA 1. PLANNING NA 75418

YEARS N/A

CARDIO CORO-NARY/ISCHEMIC

NCT02002832 SUMITOMO 1. PLANNING NA 38018

YEARS 65

YEARS PSYCH SCHIZOPHRENIA

NCT02003040 MESPERE DEVICE 1. PLANNING NA 5018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT02003508 THE ALFRED 1. PLANNING NA 80017

YEARS 19

YEARS INFECT PAPILLOMAVIRUS

NCT02003586 UNILEVER DIETARY SUP.

1. PLANNING NA 1220

YEARS 50

YEARS HEALTHY/PHARM

NCT02004821 NESTLE DIETARY SUP.

1. PLANNING NA 7018

YEARS 35

YEARS ENDO MALNUTRITION

NCT02005198 NOVO NORDISK OTHER 1. PLANNING NA 5023

YEARS 79

YEARS ENDO GROWTH HORMONE

NCT02005328 PIERRE FABRE DEVICE 1. PLANNING NA 24 18 YEARS N/A ENT DRY MOUTH

NCT02005692 LEAF HEALTHCARE

DEVICE 1. PLANNING NA 7018

YEARS N/A

DERM WOUND/ULCER

NCT02006069 ST JUDE DEVICE 1. PLANNING NA 1,25618

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT02006173 SCIVISION DRUG 1. PLANNING NA 4030

YEARS 60

YEARS DERM NASOLA-BIAL FOLDS

NCT02006862 ELPEN 1. PLANNING NA 500 18 YEARS 90 YEARS PSYCH BIPOLAR

NCT02000804 GSK DRUG 2. RECRUITING 1 2418

YEARS 45

YEARS CARDIO PERIPH VASC

NCT02000934 MILLENNIUM DRUG 2. RECRUITING 1 7518

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02000947 MEDIMMUNE DRUG 2. RECRUITING 1 156 18 YEARS N/A ONC RESP: LUNG

NCT02001389 ENVIVO DRUG 2. RECRUITING 1 16 18 YEARS 50 YEARS HEALTHY/PHARM

NCT02002936 SYMBIO DRUG 2. RECRUITING 1 1220

YEARS N/A

ONC HEM: MY-ELODYSPLASTIC

NCT02003092 REXAHN DRUG 2. RECRUITING 1 2018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02003131 TRANSLATIONAL BIO.

BIOLOGICAL 2. RECRUITING 1 4018

YEARS 80

YEARS RHEUM ARTHRITIS/GOUT

New Studies, from Page 4

(See New Studies, Page 6)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

Page 6: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 6

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT02003677 NOVO NORDISK DRUG 2. RECRUITING 1 4418

YEARS N/A ENDO DIABETES

NCT02004548 JIANGSU SIMCERE

DRUG 2. RECRUITING 1 4918

YEARS 74

YEARS ONC SOLID TUMOR/CANCER

NCT02004587 LG LIFE DRUG 2. RECRUITING 1 28 18 YEARS 75 YEARS GI LIVER FAILURE

NCT02004717 DAIICHI SANKYO

DRUG 2. RECRUITING 1 3820

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02005315 ONCOMED DRUG 2. RECRUITING 1 34 18 YEARS 90 YEARS ONC GI: PANCREAS

NCT02005991 PFIZER DRUG 2. RECRUITING 1 12 18 YEARS 55 YEARS HEALTHY/PHARM

NCT02006277 PFIZER DRUG 2. RECRUITING 1 20 18 YEARS 55 YEARS HEALTHY/PHARM

NCT02006485 TG THERAPEUTICS

DRUG 2. RECRUITING 1 10018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02000349 REPROGENETICS OTHER 2. RECRUITING 2 186 18 YEARS 42 YEARS O&G INFERTILITY

NCT02002208 ATOPIX DRUG 2. RECRUITING 2 20018

YEARS 40

YEARS ALLERGY ECZE-MA/DERMATITIS

NCT02003118 AKRON DRUG 2. RECRUITING 2 26040

YEARS 75

YEARS RHEUM ARTHRITIS/GOUT

NCT02003365 FLEXION DRUG 2. RECRUITING 2 4040

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT02004028 VERASTEM DRUG 2. RECRUITING 2 20 18 YEARS N/A ONC RESP: PLEURA

NCT02004041 VANDA DRUG 2. RECRUITING 2 6818

YEARS 65

YEARS ALLERGY ECZE-MA/DERMATITIS

NCT02004119 KYOWA DRUG 2. RECRUITING 2 9020

YEARS 64

YEARS ALLERGY ECZE-MA/DERMATITIS

NCT02004704 GENZYME DRUG 2. RECRUITING 2 70 18 YEARS N/A ENDO LIPIDOSIS

NCT02005458 XIAMEN AMOYTOP

DRUG 2. RECRUITING 2 8018

YEARS 70

YEARS ONC RESP: LUNG

NCT02006719 AUXILIUM BIOLOGICAL 2. RECRUITING 2 30018

YEARS N/A

ORTH TENDO DISEASE

NCT02007512 MEDIVATION DRUG 2. RECRUITING 2 240 18 YEARS N/A ONC BREAST

NCT02003313 BEIJING MINHAI BIOLOGICAL 2. RECRUITING 3 1,260 2 YEARS 30

YEARS INFECT MENINGITIS

NCT02003495 BEIJING MINHAI BIOLOGICAL 2. RECRUITING 3 2,1952

MONTHS 6

YEARS INFECT MENINGITIS

NCT02003742 RECORDATI DRUG 2. RECRUITING 3 34045

YEARS N/A

UROLOGY URI-NARY SYMPTOMS

NCT02003924 MEDIVATION DRUG 2. RECRUITING 3 1,56018

YEARS N/A

ONC UROLOGY: PROSTATE

NCT02004522 INFINITY DRUG 2. RECRUITING 3 30018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02005666 CADILA DRUG 2. RECRUITING 3 850 12 YEARS 40 YEARS DERM ACNE

NCT02006732 BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT02007434 KYTHERA OTHER 2. RECRUITING 3 8018

YEARS 65

YEARS ANEST PAIN

NCT02000388 CITRUS VALLEY DRUG 2. RECRUITING 4 15 25 YEARS 64 YEARS GI SURG

New Studies, from Page 5

(See New Studies, Page 7)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

Page 7: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 7

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT02005068 ORLANDO DRUG 2. RECRUITING 4 3018

YEARS N/A

HEM BONE MARROW

NCT02005536 SANOFI BIOLOGICAL 2. RECRUITING 4 60 4 YEARS 6 YEARS INFECT POLIO

NCT02000271 TRIHEALTH PROCEDURE 2. RECRUITING NA 10418

YEARS 85

YEARS O&G PELVIC DISEASE

NCT02000310 O ALPAN 2. RECRUITING NA 30 N/A N/A ENDO METAB/NUTR

NCT02000830 INFACARE DRUG 2. RECRUITING NA 90 N/A 52

MONTHS HEALTHY/PHARM

NCT02001233 SINOVAC BIOLOGICAL 2. RECRUITING NA 10,0776

MONTHS 35

MONTHS INFECT HAND, FOOT, MOUTH

NCT02001350 NOBLEWELL OTHER 2. RECRUITING NA 3018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT02002065 SINOVAC BIOLOGICAL 2. RECRUITING NA 30018

MONTHS 35

MONTHS INFECT HEPATITIS A

NCT02002637 COTERA DEVICE 2. RECRUITING NA MISS-ING

30 YEARS

65 YEARS

RHEUM ARTHRITIS/GOUT

NCT02003235 VISIOR DEVICE 2. RECRUITING NA 12 5 YEARS 8 YEARS OPHTHAL EYE DISEASE

NCT02003404 HOLLISTER DEVICE 2. RECRUITING NA 2518

YEARS 80

YEARS DERM SCAR/INJURY

NCT02003521 MEDICAL ACOUSTICS

DEVICE 2. RECRUITING NA 4812

YEARS N/A

ALLERGY ASTHMA

NCT02003612 AMGEN OTHER 2. RECRUITING NA 1,50015

YEARS N/A

ONC HEM: LEUKEMIA

NCT02003898 MEDTRONIC 2. RECRUITING NA 1,200 16 YEARS N/A ENDO DIABETES

NCT02004353 COCHLEAR DEVICE 2. RECRUITING NA 500 10 YEARS N/A ENT HEARING LOSS

NCT02005133 NOVARTIS 2. RECRUITING NA 20050

YEARS N/A

OPHTHAL MACULAR DEGENERATION

NCT02006758 ST JUDE DEVICE 2. RECRUITING NA 50018

YEARS N/A

CARDIO HYPERTENSION

NCT02007473 MACO 2. RECRUITING NA 80 N/A N/A HEALTHY/PHARM

NCT02000765 GSK DRUG 3. ONGOING 1 630

YEARS 55

YEARS INFECT INFLUENZA/FLU

NCT02003547 AMAKEM DRUG 3. ONGOING 1 2135

YEARS 65

YEARS OPHTHAL GLAUCOMA

NCT02005757 CHONG KUN DANG

DRUG 3. ONGOING 2 6020

YEARS 80

YEARS RHEUM ARTHRITIS/GOUT

NCT02001129 WILLS EYE BEHAVIORAL 3. ONGOING NA 1,00018

YEARS N/A

OPHTHAL EYE DISEASE

NCT02001155 WILLS EYE PROCEDURE 3. ONGOING NA 4021

YEARS 90

YEARS OPHTHAL GLAUCOMA

NCT02005341 PIONEER SURGICAL

DEVICE 3. ONGOING NA 4021

YEARS N/A

ORTH DISC DEGENARATIVE

NCT02001571 COUGAR DRUG 4. COMPLETED 1 2440

YEARS 80

YEARS ONC UROLOGY: PROSTATE

New Studies, from Page 6

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Studies, Page 8)(Return to Page 1)

Page 8: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 8

NeW reSulTS

This table lists all industry-sponsored studies with results posted during the past week.

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT00984282 BAYER DRUG 3. ONGOING 3 417 18 YEARS N/A ONC ENDO: THYROID

NCT01381575 GSK BIOLOGICAL 3. ONGOING 3 1,447 9 YEARS 25

YEARS INFECT PAPILLOMAVIRUS

NCT00957021 STRYKER DEVICE 3. ONGOING NA 40921

YEARS 80

YEARS ORTH HIP/KNEE REPLACEMENT

NCT00452673 BMS DRUG 4. COMPLETED 1 52 18 YEARS N/A ONC BREAST

NCT00796003 JANSSEN DRUG 4. COMPLETED 1 3920

YEARS N/A

ONC HEM: MYELODYSPLASTIC

NCT01396265 BOEHRINGER INGELHEIM

DRUG 4. COMPLETED 1 2218

YEARS 55

YEARS HEALTHY/PHARM

NCT00089635 AMGEN DRUG 4. COMPLETED 2 203 18 YEARS N/A ONC GI: COLORECTAL

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT02004678 DAIICHI SANKYO DRUG 4. COMPLETED 1 40 18 YEARS 60 YEARS ENDO DIABETES

NCT02007005 ABNOBA DRUG 4. COMPLETED 1 3718

YEARS 80

YEARS ONC UROLOGY: BLADDER

NCT02004093 HOFFMANN-LA ROCHE

DRUG 4. COMPLETED 2 15218

YEARS N/A ONC O&G: OVARY

NCT02004886 MERCK DRUG 4. COMPLETED 2 72 21 YEARS 65 YEARS ENDO DIABETES

NCT02005484 HOFFMANN-LA ROCHE

DRUG 4. COMPLETED 2 618

YEARS 75

YEARS ONC GI: ESOPHA-GEAL/GASTRIC

NCT02005549 HOFFMANN-LA ROCHE

DRUG 4. COMPLETED 2 1818

YEARS 70

YEARS ONC BREAST

NCT02006667 HOFFMANN-LA ROCHE

DRUG 4. COMPLETED 2 1318

YEARS N/A

ONC UROLOGY: BLADDER

NCT02005562 HOFFMANN-LA ROCHE

DRUG 4. COMPLETED 3 26318

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT02006706 HOFFMANN-LA ROCHE

DRUG 4. COMPLETED 3 1518

YEARS 80

YEARS RHEUM ARTHRITIS/GOUT

NCT02000401 CITRUS VALLEY DRUG 4. COMPLETED 4 15 18 YEARS 64 YEARS INFECT CYSTITIS

NCT02003534 ALLERGAN DRUG 4. COMPLETED 4 459 N/A N/A OPHTHAL GLAUCOMA

NCT01130974 BAUSCH & LOMB DEVICE 4. COMPLETED NA 200 18 YEARS N/A OPHTHAL MYOPIA

NCT02002728 ORTEK 4. COMPLETED NA 200 6 YEARS 9 YEARS DENTAL CARIES

NCT02002975 TAKEDA DRUG 4. COMPLETED NA 18,197 20 YEARS 74 YEARS ENDO DIABETES

NCT02003014 TAKEDA DRUG 4. COMPLETED NA 899 N/A N/A ENDO DIABETES

NCT02005393 FUJIFILM DEVICE 4. COMPLETED NA 20 21 YEARS N/A GI SCOPY

NCT02005731 INITIA DEVICE 4. COMPLETED NA 5820

YEARS 80

YEARS UROLOGY ERECTILE

NCT02006992 ABBOTT OTHER 4. COMPLETED NA 195 N/A 9 DAYS OTHER UNSPECIFIC

New Studies, from Page 7

(See New results, Page 9)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

Page 9: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 9

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT00261950 AMGEN DRUG 4. COMPLETED 2 11018

YEARS N/A

ENDO HYPERPARA-THYROIDISM

NCT00268203 GSK BIOLOGICAL 4. COMPLETED 2 769 18 YEARS N/A ONC HEM: LYMPHOMA

NCT00511238 ONYX DRUG 4. COMPLETED 2 302 18 YEARS N/A ONC HEM: MYELOMA

NCT00690482 ASTRAZENECA DRUG 4. COMPLETED 2 118 40 YEARS N/A RESP COPD

NCT00713349 HEALTHPOINT DRUG 4. COMPLETED 2 25 18 YEARS N/A DERM WOUND/ULCER

NCT00819234 BMS DRUG 4. COMPLETED 2 274 18 YEARS 65 YEARS ENDO OBESITY

NCT01109524 BMS DRUG 4. COMPLETED 2 72 18 YEARS N/A ONC RESP: LUNG

NCT01118962 UCB DRUG 4. COMPLETED 2 3916

YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01199939 TIBOTEC DRUG 4. COMPLETED 2 54 18 YEARS N/A INFECT HIV/AIDS

NCT01447017 DERMAGEN DRUG 4. COMPLETED 2 69 12 YEARS N/A INFECT OTITIS

NCT01461655 LEO DRUG 4. COMPLETED 2 40 18 YEARS 35 YEARS DERM ACNE

NCT01484197 NOVARTIS DRUG 4. COMPLETED 2 36 18 YEARS N/A ALLERGY ASTHMA

NCT00162032 LANTHEUS DRUG 4. COMPLETED 3 445 4 YEARS 16 YEARS INFECT KAWASAKI

NCT00257010 JANSSEN DRUG 4. COMPLETED 3 44712

YEARS 17

YEARS NEUR MIGRAINE/H-ACHE

NCT00343889 SANOFI BIOLOGICAL 4. COMPLETED 3 379 42 DAYS 50 DAYS INFECT DIPHTHERIA

NCT00354484 LUITPOLD DRUG 4. COMPLETED 3 291 N/A N/A HEM ANEMIA

NCT00396292 LUITPOLD DRUG 4. COMPLETED 3 361 N/A N/A HEM ANEMIA

NCT00667446 ABBVIE DRUG 4. COMPLETED 3 72 N/A N/A ENDO PRECOCIOUS PUBERTY

NCT00996216 GSK DRUG 4. COMPLETED 3 27 18 YEARS N/A INFECT HEPATITIS C

NCT01066520 HEILMITTEL HEEL

DRUG 4. COMPLETED 3 44918

YEARS 40

YEARS ORTH TENDO DIS-EASE

NCT01070784 ASTRAZENECA DRUG 4. COMPLETED 3 328 40 YEARS N/A RESP COPD

NCT01165554 GE HEALTHCARE DRUG 4. COMPLETED 3 203 55 YEARS N/A NEUR BRAIN DISEASE

NCT01220869 FERRING DRUG 4. COMPLETED 3 11020

YEARS N/A

ONC UROLOGY: PROSTATE

NCT01292239 JANSSEN DRUG 4. COMPLETED 3 183 20 YEARS 70 YEARS INFECT HEPATITIS C

NCT01392547 NOVO NORDISK

DRUG 4. COMPLETED 3 7212

YEARS N/A

CARDIO THROMB/COAG

NCT01473836 PFIZER DRUG 4. COMPLETED 3 3816

YEARS 79

YEARS INFECT INTRABDOMINAL

NCT01535560 ALCON DRUG 4. COMPLETED 3 5896

MONTHS N/A INFECT OTITIS

NCT01554163 MERCK DRUG 4. COMPLETED 3 23940

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01607112 GSK BIOLOGICAL 4. COMPLETED 3 11918

YEARS N/A

INFECT INFLUENZA/FLU

NCT00828412 PROMIUS DEVICE 4. COMPLETED 4 1003

MONTHS 12

YEARS ALLERGY ECZEMA/DERMATITIS

NCT01216072 NOVARTIS DRUG 4. COMPLETED 4 1,05318

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

(See New results, Page 10)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

New results, from Page 8

Page 10: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 10

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Study Status, Page 11)(Return to Page 1)

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01892046 ESANEX DRUG 2. RECRUITING 1 2018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01926509 MERCK DRUG 2. RECRUITING 1 1818

YEARS 70

YEARS CARDIO HYPER-TENSION PULM

NCT01943721 FORSIGHT DRUG 2. RECRUITING 1 2018

YEARS N/A

OPHTHAL GLAUCOMA

NCT01959594 PFIZER DRUG 2. RECRUITING 1 50 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01962103 CELGENE DRUG 2. RECRUITING 1 105 6 MONTHS 21 YEARS ONC CNS: BRAIN

NCT01975519 TRACON DRUG 2. RECRUITING 1 1818

YEARS N/A

ONC ORTH: SARCOMA

NCT01981681 PFIZER DRUG 2. RECRUITING 1 46 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01981694 PFIZER DRUG 2. RECRUITING 1 28 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01982630 MERCK DRUG 2. RECRUITING 1 48 18 YEARS 69 YEARS ENDO DIABETES

NCT01986283 PFIZER DRUG 2. RECRUITING 1 6018

YEARS 55

YEARS PSYCH ABUSE OPIOD/HEROIN

NCT01995526 ELI LILLY DRUG 2. RECRUITING 1 10 20 YEARS 45 YEARS HEALTHY/PHARM

NCT01783938 BMS BIOLOGICAL 2. RECRUITING 2 10018

YEARS N/A

ONC DERM: MELANOMA

NCT01887327 INFACARE DRUG 2. RECRUITING 2 90 N/A 72 HOURS PED JAUNDICE

NCT01890746 GSK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC HEM: LEUKEMIA

NCT01925274 PFIZER DRUG 2. RECRUITING 2 150 18 YEARS N/A ONC GI: COLORECTAL

NeW STuDy STaTuS

This table lists studies that reported updates in their status in the past week such as recruiting, ongoing or completed.

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01525173 ALLERGAN DRUG 4. COMPLETED 4 137 18 YEARS N/A OPHTHAL GLAUCOMA

NCT01130974 BAUSCH & LOMB DEVICE 4. COMPLETED NA 200 18 YEARS N/A OPHTHAL MYOPIA

NCT01278030 ST JUDE PROCEDURE 4. COMPLETED NA 78 N/A N/A CARDIO CARDIO-MYOP/FAILURE

NCT01330290 UCB DRUG 4. COMPLETED NA 148 18 YEARS N/A NEUR PARKINSON

NCT01523964 DART OTHER 4. COMPLETED NA 92 3 YEARS 12

YEARS NEUR MUSCULAR DYSTROPHY

NCT01607593 PFIZER DRUG 4. COMPLETED NA 12318

YEARS N/A

PSYCH STRESS/PTSD

NCT01614600 ALCON DEVICE 4. COMPLETED NA 88 18 YEARS N/A OPHTHAL DRY EYE

NCT01799239 COLOPLAST DEVICE 4. COMPLETED NA 32 18 YEARS N/A GI STOMY

NCT01108523 HEALTHPOINT DEVICE 7. TERMINATED 0 7 18 YEARS N/A DERM SKIN DISEASE

NCT01583647 MERCK DRUG 7. TERMINATED 1 1010

YEARS 16

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01235741 BMS DRUG 7. TERMINATED 2 213 18 YEARS 65 YEARS ENDO OBESITY

NCT00926575 SOLIGENIX DRUG 7. TERMINATED 3 140 18 YEARS N/A INFECT ENTERITIS

New results, from Page 9

Page 11: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 11

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01946945 REPROGENETICS GENETIC 2. RECRUITING 2 240 22 YEARS 42 YEARS O&G INFERTILITY

NCT01951274 TIGERCAT DRUG 2. RECRUITING 2 260 18 YEARS 65 YEARS DERM PRURITUS

NCT01954628 AQUINOX DRUG 2. RECRUITING 2 400 40 YEARS N/A RESP COPD

NCT01959412 NOVARTIS DRUG 2. RECRUITING 2 90 18 YEARS N/A ALLERGY ASTHMA

NCT01972568 EMD SERONO DRUG 2. RECRUITING 2 27918

YEARS N/A

RHEUM LUPUS ERYTHEM.

NCT01972776 NOVARTIS DRUG 2. RECRUITING 2 122 35 YEARS 75 YEARS RESP COPD

NCT01995058 EXELIXIS DRUG 2. RECRUITING 2 28018

YEARS N/A

ONC UROLOGY: PROSTATE

NCT01999582 CELGENE BIOLOGICAL 2. RECRUITING 2 60 18 YEARS N/A HEM ANEMIA

NCT01112722 APIMEDS BIOLOGICAL 2. RECRUITING 3 33030

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01200758 HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 40518

YEARS N/A

ONC HEM: LYMPHOMA

NCT01239732 HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 1,00018

YEARS N/A ONC O&G: OVARY

NCT01358877 HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 4,80018

YEARS N/A ONC BREAST

NCT01691755 HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 20018

YEARS N/A ENDO DIABETES

NCT01693120 MEDTRONIC DEVICE 2. RECRUITING 3 30018

YEARS 70

YEARS CARDIO ARRHYT/FIBRILL

NCT01879618 PFIZER DRUG 2. RECRUITING 3 15018

YEARS 75

YEARS UROLOGY KIDNEY FAILURE

NCT01885208 NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01930188 NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01946412 VERTEX DRUG 2. RECRUITING 3 33 2 YEARS N/A RESP CYSTIC FIBROSIS

NCT01947946 ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 84618

YEARS 75

YEARS ALLERGY ASTHMA

NCT01950455 NAVIDEA DRUG 2. RECRUITING 3 275 40 YEARS N/A NEUR PARKINSON

NCT01950468 NAVIDEA DRUG 2. RECRUITING 3 275 40 YEARS N/A NEUR PARKINSON

NCT01964352 BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT01968031 KYOWA DRUG 2. RECRUITING 3 609 30 YEARS N/A NEUR PARKINSON

NCT01986881 MERCK DRUG 2. RECRUITING 3 3,900 40 YEARS N/A ENDO DIABETES

NCT01999777 UPSHER-SMITH DRUG 2. RECRUITING 3 4812

YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01539161 MEDTRONIC DEVICE 2. RECRUITING 4 102 21 YEARS N/A INFECT PARASITE

NCT01907854 NOVO NORDISK DRUG 2. RECRUITING 4 396 18 YEARS N/A ENDO DIABETES

NCT01972789 NOVARTIS DRUG 2. RECRUITING 4 33050

YEARS N/A

OPHTHAL MACULAR DEGENERATION

NCT01234259 VENTUS DEVICE 2. RECRUITING NA 60 30 YEARS N/A DERM CELLUITE

New Study Status, from Page 10

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Study Status, Page 12)(Return to Page 1)

Page 12: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 12

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01791062 TRB DEVICE 2. RECRUITING NA 1218

YEARS 50

YEARS ORTH JOINT DISEASE

NCT01801306 NEMODEVICES DEVICE 2. RECRUITING NA 1018

YEARS 75

YEARS NEUR HEMORRHAGE

NCT01811797 INITIA DEVICE 2. RECRUITING NA 4020

YEARS 80

YEARS UROLOGY ERECTILE

NCT01866982 SHARP HEALTHCARE

PROCEDURE 2. RECRUITING NA 600 N/A N/A NEUR HEMORRHAGE

NCT01882465 VISTAKON DEVICE 2. RECRUITING NA 100 18 YEARS 35 YEARS OPHTHAL MYOPIA

NCT01906138 SENSIMED DEVICE 2. RECRUITING NA 3018

YEARS N/A

OPHTHAL GLAUCOMA

NCT01924728 QRS DEVICE 2. RECRUITING NA 12021

YEARS 70

YEARS UROLOGY INCONTINENCE

NCT01953874 RESMED DEVICE 2. RECRUITING NA 21521

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01954108 TRB DEVICE 2. RECRUITING NA 8018

YEARS 75

YEARS ORTH TENDO DISEASE

NCT01962168 COOK DEVICE 2. RECRUITING NA 200 18 YEARS N/A ONC GI: BILIARY

NCT01976559 LIFEBRIDGE DEVICE 2. RECRUITING NA 1618

YEARS 80

YEARS NEUR HYDROCEPHALUS

NCT01984996 INSIGHTRA DEVICE 2. RECRUITING NA 150 18 YEARS N/A GI HERNIA

NCT01997736 TORAY DEVICE 2. RECRUITING NA 3518

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01263353 NOVARTIS DRUG 3. ONGOING 1 3618

YEARS N/A

ONC ENDO: NEUROENDO

NCT01403285 IMMATICS BIO DRUG 3. ONGOING 1 25 18 YEARS N/A ONC CNS: GLIOMA

NCT01482156 NOVARTIS DRUG 3. ONGOING 1 4618

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01590654 GILEAD DRUG 3. ONGOING 1 48 18 YEARS 65 YEARS INFECT HEPATITIS B

NCT01610050 NOVARTIS DRUG 3. ONGOING 1 1418

YEARS N/A

ONC UROLOGY: PROSTATE

NCT01823887 CYBERONICS DEVICE 3. ONGOING 1 6018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01919944 VANDA DRUG 3. ONGOING 1 1218

YEARS 45

YEARS DERM PRURITUS

NCT01941511 PFIZER DRUG 3. ONGOING 1 42 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01980615 PEARL DRUG 3. ONGOING 1 84 18 YEARS 45 YEARS HEALTHY/PHARM

NCT01981005 HOFFMANN-LA ROCHE

DRUG 3. ONGOING 1 618

YEARS 45

YEARS HEALTHY/PHARM

NCT01981486 PFIZER DRUG 3. ONGOING 1 6218

YEARS 55

YEARS NEUR MIGRAINE/ H-ACHE

NCT01981499 PFIZER DRUG 3. ONGOING 1 3318

YEARS 55

YEARS NEUR MIGRAINE/ H-ACHE

NCT00506142 SPECTRUM DRUG 3. ONGOING 2 5018

YEARS N/A

ONC DERM: MELANOMA

NCT01210495 PFIZER DRUG 3. ONGOING 2 222 18 YEARS N/A ONC GI: LIVER

New Study Status, from Page 11

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Study Status, Page 13)(Return to Page 1)

Page 13: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 13

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01283724 BAYER DRUG 3. ONGOING 2 11112

YEARS 17

YEARS O&G ENDOMETRIOSIS

NCT01397409 ALLERGAN DRUG 3. ONGOING 2 27150

YEARS N/A

OPHTHAL MACULAR DEGENERATION

NCT01496742 GENENTECH DRUG 3. ONGOING 2 259 18 YEARS N/A ONC RESP: LUNG

NCT01565083 HOFFMANN-LA ROCHE

DRUG 3. ONGOING 2 21318

YEARS N/A ONC BREAST

NCT01636843 NOVO NORDISK DRUG 3. ONGOING 2 26818

YEARS 75

YEARS RHEUM INFLAMMATION

NCT01676935 ABBVIE DRUG 3. ONGOING 2 35055

YEARS 90

YEARS NEUR ALZHEIMER/DEMENT

NCT01681290 CEBIX DRUG 3. ONGOING 2 240 18 YEARS 65 YEARS NEUR NEUROPATHY

NCT01692366 SANOFI DRUG 3. ONGOING 2 2020

YEARS N/A

HEM MYELOFIBROSIS

NCT01709149 CYTOKINETICS DRUG 3. ONGOING 2 680 18 YEARS N/A NEUR ALS

NCT01728064 EDISON DRUG 3. ONGOING 2 60 18 YEARS 45 YEARS NEUR ATAXIA

NCT01748344 ONO PHARMA DRUG 3. ONGOING 2 60 18 YEARS 65 YEARS ALLERGY RHINITIS

NCT01987986 AUXILIUM BIOLOGICAL 3. ONGOING 2 144 18 YEARS 45 YEARS DERM CELLUITE

NCT00980538 JANSSEN DRUG 3. ONGOING 3 170 6 YEARS 18 YEARS INFECT HIV/AIDS

NCT01266993 GSK BIOLOGICAL 3. ONGOING 3 414 4 YEARS 16

YEARS INFECT MENINGOCOCCAL

NCT01281254 AMGEN DRUG 3. ONGOING 3 22318

YEARS N/A

ONC O&G: FALLOPIAN TUBE

NCT01340898 GSK BIOLOGICAL 3. ONGOING 3 750 6 WEEKS 12

WEEKS INFECT TETANUS

NCT01398644 SANQUIN OTHER 3. ONGOING 3 4018

YEARS 90

YEARS HEM HEMOCHRO-MATOSIS

NCT01455415 PFIZER DRUG 3. ONGOING 3 300 18 YEARS N/A NEUR NEUROPATHY

NCT01513850 SK CHEMICALS DRUG 3. ONGOING 3 80 18 YEARS 64 YEARS INFECT HEPATITIS B

NCT01614886 NOVARTIS DRUG 3. ONGOING 3 7950

YEARS 85

YEARS NEUR ALZHEIMER/DEMENT

NCT01727986 HOFFMANN-LA ROCHE

DRUG 3. ONGOING 3 11 9 YEARS 18

YEARS RHEUM ARTHRITIS/GOUT

NCT01733758 GSK DRUG 3. ONGOING 3 475 20 YEARS N/A ENDO DIABETES

NCT01743651 OSMOTICA DRUG 3. ONGOING 3 32118

YEARS 65

YEARS NEUR SPASTICITY/PALSY

NCT01777282 GSK DRUG 3. ONGOING 3 360 20 YEARS N/A ENDO DIABETES

NCT01844232 OSMOTICA DRUG 3. ONGOING 3 15018

YEARS 70

YEARS NEUR MULTIPLE SCLEROSIS

NCT01861522 MITSUBISHI DRUG 3. ONGOING 3 450 7 YEARS 15 YEARS ALLERGY RHINITIS

NCT01888497 PFIZER DRUG 3. ONGOING 3 52 25 YEARS 55 YEARS HEALTHY/PHARM

NCT01094184 HOFFMANN-LA ROCHE

DRUG 3. ONGOING 4 4618

YEARS N/A ONC BREAST

New Study Status, from Page 12

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Study Status, Page 14)(Return to Page 1)

Page 14: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 14

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01429792 HOFFMANN-LA ROCHE

DRUG 3. ONGOING 4 93918

YEARS N/A INFECT HEPATITIS C

NCT01591902 EMD SERONO DRUG 3. ONGOING 4 648 18 YEARS N/A OPHTHAL DIABETIC

NCT01613417 BRACCO DRUG 3. ONGOING 4 20618

YEARS N/A

NEUR BRAIN DISEASE

NCT01645735 CEREXA DRUG 3. ONGOING 4 49 18 YEARS N/A INFECT DISEASE

NCT01675427 HOFFMANN-LA ROCHE

OTHER 3. ONGOING 4 4,76518

YEARS N/A INFECT HEPATITIS C

NCT01811186 MUNDIPHARMA DRUG 3. ONGOING 4 26020

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT00076960 INFACARE DRUG 3. ONGOING NA 50 N/A 1 WEEK PED JAUNDICE

NCT01091506 PAMLAB OTHER 3. ONGOING NA 5018

YEARS 68

YEARS PSYCH SCHIZOPHRENIA

NCT01429220 GREAT LAKES NEURO.

3. ONGOING NA 1521

YEARS 90

YEARS NEUR PARKINSON

NCT01598597 GENENTECH 3. ONGOING NA 276 18 YEARS N/A ONC BREAST

NCT01688843 BOSTON SCIENTIFIC

DEVICE 3. ONGOING NA 1,03018

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01754194 COVIDIEN PROCEDURE 3. ONGOING NA 275 18 YEARS 65 YEARS ENDO OBESITY

NCT01761162 BIOTRONIK DEVICE 3. ONGOING NA 24518

YEARS N/A

CARDIO PACEMAKER/ICD

NCT01766947 SENSIMED DEVICE 3. ONGOING NA 2018

YEARS N/A

OPHTHAL GLAUCOMA

NCT01814852 INITIA DEVICE 3. ONGOING NA 6020

YEARS 80

YEARS UROLOGY ERECTILE

NCT01947894 PFIZER OTHER 3. ONGOING NA 90018

YEARS N/A

ENDO GROWTH HORMONE

NCT01533285 JANSSEN BIOLOGICAL 4. COMPLETED 0 3825

YEARS N/A

PSYCH DEPRESSION

NCT00911066 MILLENNIUM DRUG 4. COMPLETED 1 7218

YEARS N/A

ONC HEM: LEUKEMIA

NCT00932698 MILLENNIUM DRUG 4. COMPLETED 1 6018

YEARS N/A

ONC HEM: MYELOMA

NCT00963820 MILLENNIUM DRUG 4. COMPLETED 1 6018

YEARS N/A

ONC HEM: MYELOMA

NCT01211483 DAIICHI SANKYO DRUG 4. COMPLETED 1 222 18 YEARS N/A ONC RESP: LUNG

NCT01265745 PHARMATHENE DRUG 4. COMPLETED 1 28 18 YEARS 60 YEARS INFECT ANTHRAX

NCT01332721 TRACON DRUG 4. COMPLETED 1 3818

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01512758 MILLENNIUM DRUG 4. COMPLETED 1 3618

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01527929 SANOFI DRUG 4. COMPLETED 1 2518

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01560793 VAXINNATE BIOLOGICAL 4. COMPLETED 1 20018

YEARS 49

YEARS INFECT INFLUENZA/FLU

New Study Status, from Page 13

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Study Status, Page 15)(Return to Page 1)

Page 15: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 15

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01635296 HOFFMANN-LA ROCHE

DRUG 4. COMPLETED 1 4318

YEARS N/A

ONC HEM: LEUKEMIA

NCT01789593 NOVO NORDISK OTHER 4. COMPLETED 1 2718

YEARS 64

YEARS ENDO DIABETES

NCT01791049 THERAVANCE DRUG 4. COMPLETED 1 6418

YEARS 50

YEARS INFECT BACTERIAL

NCT01847404 GSK DRUG 4. COMPLETED 1 2418

YEARS 45

YEARS GI GASTRIC ULCER/BLEEDING

NCT01847417 GSK DRUG 4. COMPLETED 1 2418

YEARS 45

YEARS GI GASTRIC ULCER/BLEEDING

NCT01877785 GENENTECH DRUG 4. COMPLETED 1 21 18 YEARS N/A HEALTHY/PHARM

NCT01893866 PFIZER DRUG 4. COMPLETED 1 17 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01933503 INTERCEPT DRUG 4. COMPLETED 1 24 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01937026 ELI LILLY DRUG 4. COMPLETED 1 18 18 YEARS 65 YEARS HEALTHY/PHARM

NCT01965808 ELI LILLY DRUG 4. COMPLETED 1 16 21 YEARS 65 YEARS HEALTHY/PHARM

NCT00268203 GSK BIOLOGICAL 4. COMPLETED 2 76918

YEARS N/A

ONC HEM: LYMPHOMA

NCT00464893 NEOVII DRUG 4. COMPLETED 2 7018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT00511238 ONYX DRUG 4. COMPLETED 2 30218

YEARS N/A

ONC HEM: MYELOMA

NCT00819234 BMS DRUG 4. COMPLETED 2 27418

YEARS 65

YEARS ENDO OBESITY

NCT00831103 EPIPHANY DRUG 4. COMPLETED 2 37318

YEARS N/A

INFECT HERPES ZOSTER

NCT01310816 INFINITY DRUG 4. COMPLETED 2 10518

YEARS N/A ONC ORTH: BONE

NCT01359644 BMS DRUG 4. COMPLETED 2 20818

YEARS 70

YEARS INFECT HEPATITIS C

NCT01373554 PHARMAKING DRUG 4. COMPLETED 2 6018

YEARS 75

YEARS GI LIVER FATTY

NCT01380743 AMICUS DRUG 4. COMPLETED 2 2518

YEARS 65

YEARS NEUR GLYCOGEN STORAGE

NCT01381861 TRACON BIOLOGICAL 4. COMPLETED 2 2318

YEARS N/A ONC O&G: OVARY

NCT01488929 TARGACEPT DRUG 4. COMPLETED 2 60318

YEARS 65

YEARS PSYCH SCHIZOPHRENIA

NCT01526954 COHERA DEVICE 4. COMPLETED 2 150 18 YEARS 85 YEARS GI SURG

NCT01561456 AXELAR DRUG 4. COMPLETED 2 10018

YEARS N/A ONC RESP: LUNG

NCT01688934 PURDUE DRUG 4. COMPLETED 2 23040

YEARS 80

YEARS RHEUM ARTHRITIS/GOUT

NCT01732627 SANOFI BIOLOGICAL 4. COMPLETED 2 30156

YEARS N/A INFECT MENINGITIS

NCT01791504 COHERA DEVICE 4. COMPLETED 2 13018

YEARS N/A

DERM SKIN DISEASE

New Study Status, from Page 14

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Study Status, Page 16)(Return to Page 1)

Page 16: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 16

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01799824 ANTERIOS BIOLOGICAL 4. COMPLETED 2 5218

YEARS 70

YEARS DERM HYPERHIDROSIS

NCT01809964 ANTERIOS BIOLOGICAL 4. COMPLETED 2 10930

YEARS 60

YEARS DERM WRINKLES

NCT01820481 WHANIN DRUG 4. COMPLETED 2 209 20 YEARS 79 YEARS ALLERGY ASTHMA

NCT01907490 HATCHTECH DRUG 4. COMPLETED 2 386

MONTHS 17

YEARS DERM HEAD LICE

NCT00878709 PUMA DRUG 4. COMPLETED 3 2,84218

YEARS N/A ONC BREAST

NCT00930176 BIO BIOLOGICAL 4. COMPLETED 3 1612

YEARS N/A

HEM HAEMOPHILIA A/B

NCT01376245 GSK DRUG 4. COMPLETED 3 646 40 YEARS N/A RESP COPD

NCT01532648 SANTARUS DRUG 4. COMPLETED 3 50918

YEARS 75

YEARS GI ULCERATIVE COLITIS

NCT01686152 TEVA DRUG 4. COMPLETED 3 58918

YEARS N/A DERM KERATOSIS

NCT01686633 GSK DRUG 4. COMPLETED 3 1,04012

YEARS N/A ALLERGY ASTHMA

NCT01816139 WARNER CHILCOTT

DRUG 4. COMPLETED 3 57635

YEARS N/A

O&G VAGINA DISEASE

NCT01845649 WARNER CHILCOTT

DRUG 4. COMPLETED 3 55035

YEARS N/A

O&G VAGINA DISEASE

NCT01868009 GSK DEVICE 4. COMPLETED 3 287 40 YEARS N/A RESP COPD

NCT00538356 BIOTRONIK DEVICE 4. COMPLETED 4 72018

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01294592 GSK DRUG 4. COMPLETED 4 74250

YEARS N/A

UROLOGY PROS-TATE HYPERPLASIA

NCT01427309 SANOFI BIOLOGICAL 4. COMPLETED 4 31,98965

YEARS N/A

INFECT INFLUENZA/FLU

NCT00634621 GE HEALTHCARE

DRUG 4. COMPLETED NA 28318

YEARS N/A

ONC UROLOGY: BLADDER

NCT00742274 WL GORE DEVICE 4. COMPLETED NA 6118

YEARS 80

YEARS CARDIO ARTERIAL DISEASE

NCT00876408 SCRI 4. COMPLETED NA 3018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01034904 CSL BEHRING 4. COMPLETED NA 4814

YEARS 30

YEARS HEM HAEMOPHILIA A/B

NCT01085825 PLANNED PARENTHOOD

PROCEDURE 4. COMPLETED NA 49818

YEARS N/A O&G ABORTION

NCT01108692 BIOTRONIK OTHER 4. COMPLETED NA 60218

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01144572 ASTRAZENECA 4. COMPLETED NA 494 50 YEARS 70 YEARS ONC BREAST

NCT01146444 SPIRIG OTHER 4. COMPLETED NA 2018

YEARS 85

YEARS RHEUM LUPUS ERYTHEM.

NCT01278030 ST JUDE PROCEDURE 4. COMPLETED NA 78 N/A N/A CARDIO CARDIO-MYOP/FAILURE

New Study Status, from Page 15

(See New Study Status, Page 17)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

Page 17: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 17

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01959529 ALGERIA NOVO NORDISK DRUG 2. RECRUITING 3 7,50050

YEARS N/A ENDO DIABETES

NCT01974440 ARGENTINA JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01510028 ARGENTINA SHIRE BIOLOGICAL 2. RECRUITING 1 18 N/A 12

YEARS NEUR LEUKO-DYSTROPHY

NCT01715909 ARGENTINA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01440374 ARGENTINA GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT00642616 ARGENTINA MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01114529 ARGENTINA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01914757 ARGENTINA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01947946 ARGENTINA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01992276 AUSTRALIA CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01974440 AUSTRALIA JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT02005471 AUSTRALIA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

STuDieS opeNiNG a firST SiTe iN a NeW CouNTry

This table lists studies that launched a site in a country for the first time in the past week.

New Study Status, from Page 16

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 18)(Return to Page 1)

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01352585 SHIRE DRUG 4. COMPLETED NA 47 N/A N/A CARDIO THROMB/COAG

NCT01434732 SHARP HEALTHCARE

PROCEDURE 4. COMPLETED NA 60 N/A N/A CARDIO PERIPH VASC

NCT01436578 MERCK DRUG 4. COMPLETED NA 273 N/A N/A INFECT FUNGAL

NCT01458080 GSK DRUG 4. COMPLETED NA 1 18 YEARS N/A INFECT HEPATITIS C

NCT01545739 BIOTRONIK DEVICE 4. COMPLETED NA 12218

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01556711 BRAINSCOPE 4. COMPLETED NA 81618

YEARS 80

YEARS NEUR HEAD INJURY/TRAUMA

NCT01613287 MILTENYI DEVICE 4. COMPLETED NA 1218

YEARS 80

YEARS CARDIO HYPER-TENSION PULM

NCT01797250 COVIDIEN 4. COMPLETED NA 12 1 MONTH 18 YEARS ANEST PROCEDURE

NCT01798966 SENSIMED DEVICE 4. COMPLETED NA 1018

YEARS 90

YEARS OPHTHAL EYE DISEASE

NCT01934673 NOVO NORDISK OTHER 4. COMPLETED NA 1,667 18 YEARS N/A ENDO DIABETES

NCT01945970 UNILEVER OTHER 4. COMPLETED NA 3040

YEARS 65

YEARS CARDIO PERIPH VASC

NCT01951703 VISTAKON DEVICE 4. COMPLETED NA 136 18 YEARS 70 YEARS OPHTHAL MYOPIA

Page 18: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 18

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT02003508 AUSTRALIA THE ALFRED 1. PLANNING NA 80017

YEARS 19

YEARS INFECT PAPIL-LOMAVIRUS

NCT01510028 AUSTRALIA SHIRE BIOLOGICAL 2. RECRUITING 1 18 N/A 12

YEARS NEUR LEUKO-DYSTROPHY

NCT01890746 AUSTRALIA GSK DRUG 2. RECRUITING 2 12018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02006719 AUSTRALIA AUXILIUM BIOLOGICAL 2. RECRUITING 2 30018

YEARS N/A

ORTH TENDO DISEASE

NCT01114529 AUSTRALIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01953601 AUSTRALIA MERCK DRUG 2. RECRUITING 3 1,50050

YEARS 85

YEARS NEUR ALZHEIM-ER/DEMENT

NCT02006732 AUSTRALIA BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT02005471 AUSTRIA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02003118 AUSTRIA AKRON DRUG 2. RECRUITING 2 26040

YEARS 75

YEARS RHEUM ARTHRITIS/GOUT

NCT01114529 AUSTRIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01747915 AUSTRIA PFIZER DRUG 2. RECRUITING 3 168 5 YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT02006732 AUSTRIA BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT01727297 AUSTRIA MEDTRONIC DEVICE 2. RECRUITING NA 45018

YEARS N/A

CARDIO RRHYT/FIBRILL

NCT01974440 BELGIUM JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT02005471 BELGIUM HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01985334 BELGIUM NOVARTIS DRUG 1. PLANNING 4 5,662 40 YEARS N/A RESP COPD

NCT01693562 BELGIUM MEDIMMUNE DRUG 2. RECRUITING 1 22018

YEARS N/A

ONC DERM: MELANOMA

NCT02006277 BELGIUM PFIZER DRUG 2. RECRUITING 1 20 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01890746 BELGIUM GSK DRUG 2. RECRUITING 2 12018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01925209 BELGIUM NOVARTIS DRUG 2. RECRUITING 2 24036

YEARS 85

YEARS ORTH MUSCU-LAR DISEASE

NCT01114529 BELGIUM NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01964352 BELGIUM BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT02007473 BELGIUM MACO 2. RECRUITING NA 80 N/A N/A HEALTHY/PHARM

NCT02000700 BRAZIL JANSSEN DRUG 1. PLANNING 1 16 10 YEARS 17 YEARS ENDO DIABETES

NCT02004626 BRAZIL CRISTALIA DRUG 1. PLANNING 3 9218

YEARS 80

YEARS DERM WOUND/ULCER

NCT01510028 BRAZIL SHIRE BIOLOGICAL 2. RECRUITING 1 18 N/A 12

YEARS NEUR LEUKO-DYSTROPHY

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 19)

Studies opening a first Site in a New Country, from Page 17

(Return to Page 1)

Page 19: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 19

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01357161 BRAZIL MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT00642616 BRAZIL MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01947946 BRAZIL ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01959529 BRAZIL NOVO NORDISK DRUG 2. RECRUITING 3 7,500 50 YEARS N/A ENDO DIABETES

NCT02001545 BULGARIA ASTRAZENECA 1. PLANNING NA 75418

YEARS N/A

CARDIO CORO-NARY/ISCHEMIC

NCT01701362 BULGARIA PFIZER DRUG 2. RECRUITING 3 47018

YEARS N/A

NEUR NEURALGIA

NCT01947946 BULGARIA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01939223 CANADA BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT02005471 CANADA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01726257 CANADA ENDOLOGIX DEVICE 1. PLANNING NA 18018

YEARS N/A

CARDIO ANEURYSM

NCT02003040 CANADA MESPERE DEVICE 1. PLANNING NA 5018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01226316 CANADA ASTRAZENECA DRUG 2. RECRUITING 1 17018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01693562 CANADA MEDIMMUNE DRUG 2. RECRUITING 1 22018

YEARS N/A

ONC DERM: MELANOMA

NCT01962103 CANADA CELGENE DRUG 2. RECRUITING 1 1056

MONTHS 21

YEARS ONC CNS: BRAIN

NCT01693120 CANADA MEDTRONIC DEVICE 2. RECRUITING 3 30018

YEARS 70

YEARS CARDIO ARRHYT/FIBRILL

NCT01798485 CANADA SYNTA DRUG 2. RECRUITING 3 50018

YEARS N/A

ONC RESP: LUNG

NCT01879618 CANADA PFIZER DRUG 2. RECRUITING 3 15018

YEARS 75

YEARS UROLOGY KID-NEY FAILURE

NCT01944839 CANADA OPHTHOTECH DRUG 2. RECRUITING 3 62250

YEARS N/A

OPHTHAL MACULAR DEGENERATION

NCT01966614 CANADA SOPHIRIS DRUG 2. RECRUITING 3 44050

YEARS N/A

UROLOGY PROSTATE HYPERPLASIA

NCT01968031 CANADA KYOWA DRUG 2. RECRUITING 3 609 30 YEARS N/A NEUR PARKINSON

NCT01962168 CANADA COOK DEVICE 2. RECRUITING NA 200 18 YEARS N/A ONC GI: BILIARY

NCT00642616 CHILE MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01371734 CHILE PFIZER DRUG 2. RECRUITING 3 390 7 YEARS 17

YEARS PSYCH DEPRESSION

NCT01914757 CHILE ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT02002832 CHINA SUMITOMO 1. PLANNING NA 38018

YEARS 65

YEARS PSYCH SCHIZOPHRENIA

NCT02000804 CHINA GSK DRUG 2. RECRUITING 1 2418

YEARS 45

YEARS CARDIO PERIPH VASC

NCT02004548 CHINA JIANGSU SIMCERE

DRUG 2. RECRUITING 1 4918

YEARS 74

YEARS ONC SOLID TUMOR/CANCER

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 20)

Studies opening a first Site in a New Country, from Page 18

(Return to Page 1)

Page 20: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 20

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01524978 CHINA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 2 10118

YEARS N/A

ONC HEM: MYELOMA

NCT02005458 CHINA XIAMEN AMOYTOP

DRUG 2. RECRUITING 2 8018

YEARS 70

YEARS ONC RESP: LUNG

NCT01774786 CHINA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHAGEAL/GASTRIC

NCT02003313 CHINA BEIJING MINHAI

BIOLOGICAL 2. RECRUITING 3 1,260 2 YEARS 30

YEARS INFECT MENINGITIS

NCT02003495 CHINA BEIJING MINHAI

BIOLOGICAL 2. RECRUITING 3 2,1952

MONTHS 6 YEARS

INFECT MENINGITIS

NCT02001233 CHINA SINOVAC BIOLOGICAL 2. RECRUITING NA 10,0776

MONTHS 35

MONTHS INFECT HAND, FOOT, MOUTH

NCT02002065 CHINA SINOVAC BIOLOGICAL 2. RECRUITING NA 30018

MONTHS 35

MONTHS INFECT HEPATITIS A

NCT02007278 COLOMBIA NOVARTIS DRUG 1. PLANNING 4 40 18 YEARS N/A ENDO DIABETES

NCT02004288 CROATIA BIOGAIA DIETARY SUP.

1. PLANNING 2 30 8 YEARS 18

YEARS PSYCH ANOREXIA

NCT01270828 CROATIA PFIZER DRUG 2. RECRUITING 3 80018

YEARS N/A

NEUR NEURALGIA

NCT01458951 CROATIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT02005471 CZECH REP HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01964352 CZECH REP BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT01968031 CZECH REP KYOWA DRUG 2. RECRUITING 3 609 30 YEARS N/A NEUR PARKINSON

NCT02003612 CZECH REP AMGEN OTHER 2. RECRUITING NA 1,50015

YEARS N/A

ONC HEM: LEUKEMIA

NCT02001623 DENMARK GENMAB DRUG 1. PLANNING 1 54 18 YEARS N/A ONC O&G: OVARY

NCT02007252 DENMARK NOVARTIS DRUG 1. PLANNING 2 10045

YEARS N/A

CARDIO ANEURYSM

NCT02005471 DENMARK HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01894256 DENMARK ASTRAZENECA DRUG 2. RECRUITING 1 4218

YEARS 75

YEARS ONC SOLID TUMOR/CANCER

NCT01813422 DENMARK AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01964352 DENMARK BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT01977014 DENMARK NORDICINFU 2. RECRUITING NA 25 N/A N/A CARDIO HYPER-TENSION PULM

NCT01705574 DOMINICAN REPUBLIC

GILEAD DRUG 2. RECRUITING 3 51018

YEARS N/A INFECT HIV/AIDS

NCT01985334 ESTONIA NOVARTIS DRUG 1. PLANNING 4 5,662 40 YEARS N/A RESP COPD

NCT01114529 ESTONIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01885208 FINLAND NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 21)

Studies opening a first Site in a New Country, from Page 19

(Return to Page 1)

Page 21: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 21

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01964352 FINLAND BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT01751022 FINLAND MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT02000219 FRANCE OXTHERA BIOLOGICAL 1. PLANNING 2 8 N/A N/A UROLOGY KID-NEY DISEASE

NCT01974440 FRANCE JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT02001987 FRANCE HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 13018

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT02005471 FRANCE HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01726257 FRANCE ENDOLOGIX DEVICE 1. PLANNING NA 18018

YEARS N/A

CARDIO ANEURYSM

NCT02003586 FRANCE UNILEVER DIETARY SUP. 1. PLANNING NA 12 20 YEARS 50 YEARS HEALTHY/PHARM

NCT02004821 FRANCE NESTLE DIETARY SUP.

1. PLANNING NA 7018

YEARS 35

YEARS B6856ENDO MALNUTRITION

NCT01226316 FRANCE ASTRAZENECA DRUG 2. RECRUITING 1 17018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01693562 FRANCE MEDIMMUNE DRUG 2. RECRUITING 1 22018

YEARS N/A

ONC DERM: MELANOMA

NCT01794507 FRANCE ABBVIE DRUG 2. RECRUITING 1 3018

YEARS N/A

ONC HEM: MYELOMA

NCT01848834 FRANCE MERCK DRUG 2. RECRUITING 1 11418

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01962103 FRANCE CELGENE DRUG 2. RECRUITING 1 1056

MONTHS 21

YEARS ONC CNS: BRAIN

NCT01809340 FRANCE JANSSEN DRUG 2. RECRUITING 2 7018

YEARS 80

YEARS PSYCH DEPRESSION

NCT01925209 FRANCE NOVARTIS DRUG 2. RECRUITING 2 24036

YEARS 85

YEARS ORTH MUSCU-LAR DISEASE

NCT01114529 FRANCE NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01557244 FRANCE PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01608490 FRANCE PNEUMRX DEVICE 2. RECRUITING 3 31535

YEARS N/A

RESP EMPHYSEMA

NCT01712490 FRANCE MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01957176 FRANCE GSK DRUG 2. RECRUITING 4 100 1 YEAR N/A CARDIO THROMB/COAG

NCT01751022 FRANCE MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01839526 FRANCE GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25 YEARS ENDO FABRY

NCT02001909 GERMANY BAYER DRUG 1. PLANNING 1 3618

YEARS 45

YEARS ONC SOLID TUMOR/CANCER

NCT02000219 GERMANY OXTHERA BIOLOGICAL 1. PLANNING 2 8 N/A N/A UROLOGY KID-NEY DISEASE

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 22)

Studies opening a first Site in a New Country, from Page 20

(Return to Page 1)

Page 22: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 22

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01966471 GERMANY HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT02006693 GERMANY AQUESYS DEVICE 1. PLANNING 4 20018

YEARS N/A

OPHTHAL GLAUCOMA

NCT01726257 GERMANY ENDOLOGIX DEVICE 1. PLANNING NA 18018

YEARS N/A

CARDIO ANEURYSM

NCT01226316 GERMANY ASTRAZENECA DRUG 2. RECRUITING 1 17018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02003677 GERMANY NOVO NORDISK DRUG 2. RECRUITING 1 44 18 YEARS N/A ENDO DIABETES

NCT02004587 GERMANY LG LIFE DRUG 2. RECRUITING 1 28 18 YEARS 75 YEARS GI LIVER FAILURE

NCT01420081 GERMANY PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01939366 GERMANY GRENENTHAL DRUG 2. RECRUITING 2 35018

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT02004041 GERMANY VANDA DRUG 2. RECRUITING 2 6818

YEARS 65

YEARS

ALLERGY ECZEMA/ DERMATITIS

NCT00642616 GERMANY MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01543178 GERMANY SALIX DRUG 2. RECRUITING 3 80018

YEARS N/A

GI IRRITABLE BOWEL

NCT01693120 GERMANY MEDTRONIC DEVICE 2. RECRUITING 3 30018

YEARS 70

YEARS CARDIO ARRHYT/FIBRILL

NCT01737398 GERMANY ISIS DRUG 2. RECRUITING 3 19518

YEARS 75

YEARS NEUR NEUROPATHY

NCT01914757 GERMANY ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01964352 GERMANY BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT01968031 GERMANY KYOWA DRUG 2. RECRUITING 3 60930

YEARS N/A

NEUR PARKINSON

NCT02003742 GERMANY RECORDATI DRUG 2. RECRUITING 3 34045

YEARS N/A

UROLOGY URI-NARY SYMPTOMS

NCT02006732 GERMANY BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT02004353 GERMANY COCHLEAR DEVICE 2. RECRUITING NA 50010

YEARS N/A

ENT HEARING LOSS

NCT01114529 GREECE NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01751022 GREECE MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT02007473 GREECE MACO 2. RECRUITING NA 80 N/A N/A HEALTHY/PHARM

NCT01966471 HONG KONG HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT02005471 HUNGARY HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT00642616 HUNGARY MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01529034 HUNGARY UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 23)

Studies opening a first Site in a New Country, from Page 21

(Return to Page 1)

Page 23: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 23

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01693120 HUNGARY MEDTRONIC DEVICE 2. RECRUITING 3 30018

YEARS 70

YEARS CARDIO ARRHYT/FIBRILL

NCT01930188 HUNGARY NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01907854 HUNGARY NOVO NORDISK DRUG 2. RECRUITING 4 396 18 YEARS N/A ENDO DIABETES

NCT01751022 HUNGARY MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01114529 INDIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01930188 INDIA NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT02005666 INDIA CADILA DRUG 2. RECRUITING 3 850 12 YEARS 40 YEARS DERM ACNE

NCT02005848 ISRAEL KAMADA BIOLOGICAL 1. PLANNING 2 192 8 YEARS 25 YEARS ENDO DIABETES

NCT01890746 ISRAEL GSK DRUG 2. RECRUITING 2 12018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01529034 ISRAEL UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01560624 ISRAEL UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 ISRAEL UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01968031 ISRAEL KYOWA DRUG 2. RECRUITING 3 60930

YEARS N/A

NEUR PARKINSON

NCT01281293 ISRAEL CYBERONICS 2. RECRUITING NA 600 7 YEARS N/A NEUR EPILEPSY/SEIZURE

NCT01735188 ISRAEL ALEXION OTHER 2. RECRUITING NA 30 N/A N/A ENDO INBORN ERROR

NCT01751022 ISRAEL MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT02003235 ISRAEL VISIOR DEVICE 2. RECRUITING NA 12 5 YEARS 8 YEARS OPHTHAL EYE DISEASE

NCT02005471 ITALY HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01226316 ITALY ASTRAZENECA DRUG 2. RECRUITING 1 17018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01693562 ITALY MEDIMMUNE DRUG 2. RECRUITING 1 22018

YEARS N/A

ONC DERM: MELANOMA

NCT01962103 ITALY CELGENE DRUG 2. RECRUITING 1 105 6 MONTHS 21 YEARS ONC CNS: BRAIN

NCT01114529 ITALY NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01337089 ITALY GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01529034 ITALY UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01968031 ITALY KYOWA DRUG 2. RECRUITING 3 60930

YEARS N/A

NEUR PARKINSON

NCT02003742 ITALY RECORDATI DRUG 2. RECRUITING 3 34045

YEARS N/A

UROLOGY URI-NARY SYMPTOMS

NCT01613144 ITALY ALPHATEC 2. RECRUITING NA 15018

YEARS N/A

ENDO OSTEOPOROSIS

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 24)

Studies opening a first Site in a New Country, from Page 22

(Return to Page 1)

Page 24: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 24

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01806636 ITALY PNEUMRX DEVICE 2. RECRUITING NA 1,00025

YEARS N/A

RESP EMPHYSEMA

NCT02006758 ITALY ST JUDE DEVICE 2. RECRUITING NA 50018

YEARS N/A

CARDIO HYPERTENSION

NCT02005211 JAPAN ASTRAZENECA DRUG 1. PLANNING 1 4020

YEARS 80

YEARS HEALTHY/PHARM

NCT02002702 JAPAN NOVARTIS DRUG 1. PLANNING 2 4520

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01974440 JAPAN JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT02002221 JAPAN NOVARTIS DRUG 1. PLANNING 4 152 20 YEARS 74 YEARS ENDO DIABETES

NCT02002936 JAPAN SYMBIO DRUG 2. RECRUITING 1 1220

YEARS N/A

ONC HEM: MY-ELODYSPLASTIC

NCT02004717 JAPAN DAIICHI SANKYO

DRUG 2. RECRUITING 1 3820

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01925209 JAPAN NOVARTIS DRUG 2. RECRUITING 2 24036

YEARS 85

YEARS ORTH MUSCU-LAR DISEASE

NCT02004119 JAPAN KYOWA DRUG 2. RECRUITING 2 9020

YEARS 64

YEARS ALLERGY ECZE-MA/DERMATITIS

NCT01856309 JAPAN JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT02005536 JAPAN SANOFI BIOLOGICAL 2. RECRUITING 4 60 4 YEARS 6 YEARS INFECT POLIO

NCT02002611 KOREA, SOUTH CHONG KUN DANG

DRUG 1. PLANNING 1 2419

YEARS 55

YEARS ENDO DIABETES

NCT02004327 KOREA, SOUTH DONG WHA DRUG 1. PLANNING 1 6 20 YEARS 55 YEARS ENDO DIABETES

NCT02005744 KOREA, SOUTH CHONG KUN DANG

DRUG 1. PLANNING 1 2419

YEARS 64

YEARS GI LIVER FAILURE

NCT01966471 KOREA, SOUTH HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT02005471 KOREA, SOUTH HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01890746 KOREA, SOUTH GSK DRUG 2. RECRUITING 2 12018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01114529 LATVIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01114529 LITHUANIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01345019 LITHUANIA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01424566 LITHUANIA GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01923181 MALAYSIA NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01782131 MALAYSIA MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01751022 MALAYSIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01894022 MEXICO GSK DRUG 1. PLANNING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01114529 MEXICO NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 25)(Return to Page 1)

Studies opening a first Site in a New Country, from Page 23

Page 25: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 25

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01884675 MEXICO GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01962974 MEXICO JANSSEN BIOLOGICAL 2. RECRUITING 3 20018

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01838044 MEXICO PFIZER DRUG 2. RECRUITING 4 366 18 YEARS 75 YEARS ORTH BACK PAIN

NCT01926509 MOLDOVA MERCK DRUG 2. RECRUITING 1 1818

YEARS 70

YEARS CARDIO HYPER-TENSION PULM

NCT02000453 NETHERLANDS GSK DRUG 1. PLANNING 1 1518

YEARS 75

YEARS GI ULCERATIVE COLITIS

NCT02007252 NETHERLANDS NOVARTIS DRUG 1. PLANNING 2 10045

YEARS N/A

CARDIO ANEURYSM

NCT02005471 NETHERLANDS HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01726257 NETHERLANDS ENDOLOGIX DEVICE 1. PLANNING NA 18018

YEARS N/A

CARDIO ANEURYSM

NCT01624142 NETHERLANDS AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01925209 NETHERLANDS NOVARTIS DRUG 2. RECRUITING 2 24036

YEARS 85

YEARS ORTH MUSCU-LAR DISEASE

NCT01114529 NETHERLANDS NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01693120 NETHERLANDS MEDTRONIC DEVICE 2. RECRUITING 3 30018

YEARS 70

YEARS CARDIO ARRHYT/FIBRILL

NCT01727297 NETHERLANDS MEDTRONIC DEVICE 2. RECRUITING NA 45018

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT02002637 NETHERLANDS COTERA DEVICE 2. RECRUITING NA MISS-ING

30 YEARS

65 YEARS

RHEUM ARTHRITIS/GOUT

NCT02002767 NEW ZEALAND GILEAD DRUG 1. PLANNING 1 2018

YEARS 79

YEARS INFECT HEPATITIS C

NCT02005471 NEW ZEALAND HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01529034 NEW ZEALAND UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01114529 NORWAY NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT02006732 NORWAY BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT01977014 NORWAY NORDICINFU 2. RECRUITING NA 25 N/A N/A CARDIO HYPER-TENSION PULM

NCT02003131 PANAMA TRANSLATIONAL BIO.

BIOLOGICAL 2. RECRUITING 1 4018

YEARS 80

YEARS RHEUM ARTHRITIS/GOUT

NCT01947946 PERU ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01966471 PHILIPPINES HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT02005471 POLAND HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01546038 POLAND PFIZER DRUG 2. RECRUITING 1 26518

YEARS N/A

ONC HEM: LEUKEMIA

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 26)(Return to Page 1)

Studies opening a first Site in a New Country, from Page 24

Page 26: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 26

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01919164 POLAND EMD SERONO DRUG 2. RECRUITING 2 54540

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01424566 POLAND GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01529034 POLAND UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01701362 POLAND PFIZER DRUG 2. RECRUITING 3 470 18 YEARS N/A NEUR NEURALGIA

NCT01914757 POLAND ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01948856 POLAND PIERRE FABRE DRUG 2. RECRUITING 3 1,000 3 YEARS 4 YEARS INFECTINFLUENZA/FLU

NCT01968031 POLAND KYOWA DRUG 2. RECRUITING 3 609 30 YEARS N/A NEUR PARKINSON

NCT02003742 POLAND RECORDATI DRUG 2. RECRUITING 3 34045

YEARS N/A

UROLOGY URI-NARY SYMPTOMS

NCT01757665 POLAND EDWARDS DEVICE 2. RECRUITING NA 650 18 YEARS N/A CARDIO VALVE

NCT02001350 POLAND NOBLEWELL OTHER 2. RECRUITING NA 3018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT02003612 POLAND AMGEN OTHER 2. RECRUITING NA 1,50015

YEARS N/A

ONC HEM: LEUKEMIA

NCT02004353 POLAND COCHLEAR DEVICE 2. RECRUITING NA 50010

YEARS N/A

ENT HEARING LOSS

NCT01114529 PORTUGAL NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01114529 ROMANIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01860638 ROMANIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01914757 ROMANIA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01948856 ROMANIA PIERRE FABRE DRUG 2. RECRUITING 3 1,000 3 YEARS 4 YEARS INFECT INFLUENZA/FLU

NCT01966471 RUSSIA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01974440 RUSSIA JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01890746 RUSSIA GSK DRUG 2. RECRUITING 2 12018

YEARS N/A

ONC HEM: LEUKEMIA

NCT00642616 RUSSIA MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01114529 RUSSIA NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01814748 RUSSIA MERCK DRUG 2. RECRUITING 3 200 18 YEARS 44 YEARS ENDO DIABETES

NCT01947946 RUSSIA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01968031 SERBIA KYOWA DRUG 2. RECRUITING 3 609 30 YEARS N/A NEUR PARKINSON

NCT01751022 SERBIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT00642616 SLOVAKIA MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT02006732 SLOVAKIA BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 27)(Return to Page 1)

Studies opening a first Site in a New Country, from Page 25

Page 27: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 27

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01985334 SLOVENIA NOVARTIS DRUG 1. PLANNING 4 5,662 40 YEARS N/A RESP COPD

NCT01727297 SLOVENIA MEDTRONIC DEVICE 2. RECRUITING NA 45018

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01751022 SLOVENIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01439971 SOUTH AFRICA PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01813422 SOUTH AFRICA AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01947946 SOUTH AFRICA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT02004353 SOUTH AFRICA COCHLEAR DEVICE 2. RECRUITING NA 50010

YEARS N/A

ENT HEARING LOSS

NCT01974440 SPAIN JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT02005471 SPAIN HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01226316 SPAIN ASTRAZENECA DRUG 2. RECRUITING 1 17018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01962103 SPAIN CELGENE DRUG 2. RECRUITING 1 105 6 MONTHS 21 YEARS ONC CNS: BRAIN

NCT01939366 SPAIN GRENENTHAL DRUG 2. RECRUITING 2 35018

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT01114529 SPAIN NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01747915 SPAIN PFIZER DRUG 2. RECRUITING 3 168 5 YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01964352 SPAIN BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 80040

YEARS N/A RESP COPD

NCT02003742 SPAIN RECORDATI DRUG 2. RECRUITING 3 34045

YEARS N/A

UROLOGY URI-NARY SYMPTOMS

NCT01735188 SPAIN ALEXION OTHER 2. RECRUITING NA 30 N/A N/A ENDO INBORN ERROR

NCT01806636 SPAIN PNEUMRX DEVICE 2. RECRUITING NA 1,00025

YEARS N/A

RESP EMPHYSEMA

NCT02003612 SPAIN AMGEN OTHER 2. RECRUITING NA 1,50015

YEARS N/A

ONC HEM: LEUKEMIA

NCT02004353 SPAIN COCHLEAR DEVICE 2. RECRUITING NA 50010

YEARS N/A

ENT HEARING LOSS

NCT02007473 SPAIN MACO 2. RECRUITING NA 80 N/A N/A HEALTHY/PHARM

NCT02007252 SWEDEN NOVARTIS DRUG 1. PLANNING 2 10045

YEARS N/A

CARDIO ANEURYSM

NCT02005471 SWEDEN HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01914757 SWEDEN ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01947946 SWEDEN ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT02004106 SWITZERLAND HOFFMANN-LA ROCHE

DRUG 1. PLANNING 1 11018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02005471 SWITZERLAND HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 28)(Return to Page 1)

Studies opening a first Site in a New Country, from Page 26

Page 28: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 28

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01962103 SWITZERLAND CELGENE DRUG 2. RECRUITING 1 105 6 MONTHS 21 YEARS ONC CNS: BRAIN

NCT01806636 SWITZERLAND PNEUMRX DEVICE 2. RECRUITING NA 1,00025

YEARS N/A

RESP EMPHYSEMA

NCT02006147 TAIWAN TAIWAN LIPOSOME

DRUG 1. PLANNING 1 3020

YEARS N/A

OPHTHAL MAC-ULAR EDEMA

NCT01966471 TAIWAN HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT02005471 TAIWAN HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02006173 TAIWAN SCIVISION DRUG 1. PLANNING NA 4030

YEARS 60

YEARS DERM NASOLA-BIAL FOLDS

NCT01295827 TAIWAN MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01902290 TAIWAN AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01114529 TAIWAN NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01337089 TAIWAN GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01813422 TAIWAN AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01966471 THAILAND HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01114529 THAILAND NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01172548 TUNISIA NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01114529 TURKEY NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01697072 TURKEY AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 TURKEY MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01947946 TURKEY ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01735188 TURKEY ALEXION OTHER 2. RECRUITING NA 30 N/A N/A ENDO INBORN ERROR

NCT01585766 UKRAINE MEDIMMUNE BIOLOGICAL 2. RECRUITING 1 2818

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT00642616 UKRAINE MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01914757 UKRAINE ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01947946 UKRAINE ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 846 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT02001623 UK GENMAB DRUG 1. PLANNING 1 54 18 YEARS N/A ONC O&G: OVARY

NCT02004301 UK BIO-IMAGES DRUG 1. PLANNING 1 1218

YEARS 45

YEARS RHEUM ARTHRITIS/GOUT

NCT02000609 UK CHIESI DRUG 1. PLANNING 2 45 40 YEARS 75 YEARS RESP COPD

NCT01966471 UK HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT02005471 UK HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01726257 UK ENDOLOGIX DEVICE 1. PLANNING NA 18018

YEARS N/A

CARDIO ANEURYSM

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 29)(Return to Page 1)

Studies opening a first Site in a New Country, from Page 27

Page 29: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 29

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01683695 UK AMGEN DRUG 2. RECRUITING 1 4018

YEARS 65

YEARS RHEUM LUPUS ERYTHEM.

NCT01962103 UK CELGENE DRUG 2. RECRUITING 1 105 6 MONTHS 21 YEARS ONC CNS: BRAIN

NCT01624142 UK AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT02002208 UK ATOPIX DRUG 2. RECRUITING 2 20018

YEARS 40

YEARS ALLERGY ECZE-MA/DERMATITIS

NCT01424566 UK GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01543178 UK SALIX DRUG 2. RECRUITING 3 80018

YEARS N/A

GI IRRITABLE BOWEL

NCT01693120 UK MEDTRONIC DEVICE 2. RECRUITING 3 30018

YEARS 70

YEARS CARDIO ARRHYT/FIBRILL

NCT02003742 UK RECORDATI DRUG 2. RECRUITING 3 34045

YEARS N/A

UROLOGY URI-NARY SYMPTOMS

NCT02002637 UK COTERA DEVICE 2. RECRUITING NA MISS-ING

30 YEARS

65 YEARS

RHEUM ARTHRITIS/GOUT

NCT02003612 UK AMGEN OTHER 2. RECRUITING NA 1,50015

YEARS N/A

ONC HEM: LEUKEMIA

NCT02005133 UK NOVARTIS 2. RECRUITING NA 20050

YEARS N/A

OPHTHAL MACULAR DEGENERATION

NCT02007473 UK MACO 2. RECRUITING NA 80 N/A N/A HEALTHY/PHARM

NCT02000700 USA JANSSEN DRUG 1. PLANNING 1 16 10 YEARS 17 YEARS ENDO DIABETES

NCT02002767 USA GILEAD DRUG 1. PLANNING 1 2018

YEARS 79

YEARS INFECT HEPATITIS C

NCT02003573 USA BOEHRINGER INGELHEIM

DRUG 1. PLANNING 1 13660

YEARS N/A

ONC HEM: LEUKEMIA

NCT02004132 USA ELI LILLY DRUG 1. PLANNING 1 12 18 YEARS N/A HEALTHY/PHARM

NCT02000219 USA OXTHERA BIOLOGICAL 1. PLANNING 2 8 N/A N/A UROLOGY KID-NEY DISEASE

NCT02000882 USA US ONCOLOGY DRUG 1. PLANNING 2 40 18 YEARS N/A ONC BREAST

NCT02001688 USA KAMADA BIOLOGICAL 1. PLANNING 2 4018

YEARS 65

YEARS ENDO ALPHA 1-ANTITRYPSIN

NCT02004262 USA ADURO BIOLOGICAL 1. PLANNING 2 24018

YEARS N/A

ONC GI: PANCREAS

NCT02005523 USA REVALESIO DRUG 1. PLANNING 2 2418

YEARS 50

YEARS ORTH JOINT DISEASE

NCT02007252 USA NOVARTIS DRUG 1. PLANNING 2 10045

YEARS N/A

CARDIO ANEURYSM

NCT02004392 USA ENVIVO DRUG 1. PLANNING 3 1,00055

YEARS 85

YEARS NEUR ALZHEIM-ER/DEMENT

NCT02005471 USA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 37018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02003391 USA ALCON DRUG 1. PLANNING 4 15618

YEARS N/A

OPHTHAL GLAUCOMA

NCT01726257 USA ENDOLOGIX DEVICE 1. PLANNING NA 18018

YEARS N/A

CARDIO ANEURYSM

Studies opening a first Site in a New Country, from Page 28

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 30)(Return to Page 1)

Page 30: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 30

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT02005692 USA LEAF HEALTHCARE

DEVICE 1. PLANNING NA 7018

YEARS N/A

DERM WOUND/ULCER

NCT01962103 USA CELGENE DRUG 2. RECRUITING 1 105 6 MONTHS 21 YEARS ONC CNS: BRAIN

NCT01982630 USA MERCK DRUG 2. RECRUITING 1 48 18 YEARS 69 YEARS ENDO DIABETES

NCT01986283 USA PFIZER DRUG 2. RECRUITING 1 6018

YEARS 55

YEARS PSYCH ABUSE OPIOD/HEROIN

NCT02000934 USA MILLENNIUM DRUG 2. RECRUITING 1 7518

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02000947 USA MEDIMMUNE DRUG 2. RECRUITING 1 156 18 YEARS N/A ONC RESP: LUNG

NCT02001389 USA ENVIVO DRUG 2. RECRUITING 1 16 18 YEARS 50 YEARS HEALTHY/PHARM

NCT02003092 USA REXAHN DRUG 2. RECRUITING 1 2018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT02005315 USA ONCOMED DRUG 2. RECRUITING 1 3418

YEARS 90

YEARS ONC GI: PANCREAS

NCT02005991 USA PFIZER DRUG 2. RECRUITING 1 12 18 YEARS 55 YEARS HEALTHY/PHARM

NCT02006485 USA TG THERAPEUTICS

DRUG 2. RECRUITING 1 10018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01887327 USA INFACARE DRUG 2. RECRUITING 2 90 N/A 72 HOURS PED JAUNDICE

NCT01890746 USA GSK DRUG 2. RECRUITING 2 12018

YEARS N/A

ONC HEM: LEUKEMIA

NCT01972776 USA NOVARTIS DRUG 2. RECRUITING 2 122 35 YEARS 75 YEARS RESP COPD

NCT01995058 USA EXELIXIS DRUG 2. RECRUITING 2 28018

YEARS N/A

ONC UROLOGY: PROSTATE

NCT02000349 USA REPROGENET-ICS

OTHER 2. RECRUITING 2 18618

YEARS 42

YEARS O&G INFERTILITY

NCT02003365 USA FLEXION DRUG 2. RECRUITING 2 4040

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT02004028 USA VERASTEM DRUG 2. RECRUITING 2 2018

YEARS N/A

ONC RESP: PLEURA

NCT02004704 USA GENZYME DRUG 2. RECRUITING 2 70 18 YEARS N/A ENDO LIPIDOSIS

NCT02006719 USA AUXILIUM BIOLOGICAL 2. RECRUITING 2 30018

YEARS N/A

ORTH TENDO DISEASE

NCT02007512 USA MEDIVATION DRUG 2. RECRUITING 2 240 18 YEARS N/A ONC BREAST

NCT01112722 USA APIMEDS BIOLOGICAL 2. RECRUITING 3 33030

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01693120 USA MEDTRONIC DEVICE 2. RECRUITING 3 30018

YEARS 70

YEARS CARDIO ARRHYT/FIBRILL

NCT01947946 USA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 84618

YEARS 75

YEARS ALLERGY ASTHMA

NCT01950455 USA NAVIDEA DRUG 2. RECRUITING 3 275 40 YEARS N/A NEUR PARKINSON

NCT01950468 USA NAVIDEA DRUG 2. RECRUITING 3 275 40 YEARS N/A NEUR PARKINSON

NCT01986881 USA MERCK DRUG 2. RECRUITING 3 3,900 40 YEARS N/A ENDO DIABETES

NCT01999777 USA UPSHER-SMITH DRUG 2. RECRUITING 3 4812

YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT02003924 USA MEDIVATION DRUG 2. RECRUITING 3 1,56018

YEARS N/A

ONC UROLOGY: PROSTATE

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening a first Site in a New Country, Page 31)(Return to Page 1)

Studies opening a first Site in a New Country, from Page 29

Page 31: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 31

STuDieS opeNiNG aDDiTioNal SiTeS iN a CouNTry

This table lists studies that launched additional sites in a country in the past week.

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01860638 ALBANIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01172548 ALGERIA NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01966471 ARGENTINA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01782131 ARGENTINA MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01885208 ARGENTINA NOVO NORDISK

DRUG 2. RECRUITING 3 79818

YEARS N/A ENDO DIABETES

NCT01930188 ARGENTINA NOVO NORDISK

DRUG 2. RECRUITING 3 1,20018

YEARS N/A ENDO DIABETES

NCT01959529 ARGENTINA NOVO NORDISK

DRUG 2. RECRUITING 3 7,50050

YEARS N/A ENDO DIABETES

NCT01543503 ARGENTINA HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01939223 AUSTRALIA BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01966471 AUSTRALIA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 32)(Return to Page 1)

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT02004522 USA INFINITY DRUG 2. RECRUITING 3 30018

YEARS N/A

ONC HEM: LEUKEMIA

NCT02005666 USA CADILA DRUG 2. RECRUITING 3 850 12 YEARS 40 YEARS DERM ACNE

NCT02007434 USA KYTHERA OTHER 2. RECRUITING 3 80 18 YEARS 65 YEARS ANEST PAIN

NCT02005068 USA ORLANDO DRUG 2. RECRUITING 4 3018

YEARS N/A

HEM BONE MARROW

NCT01543503 USA HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01953874 USA RESMED DEVICE 2. RECRUITING NA 21521

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01962168 USA COOK DEVICE 2. RECRUITING NA 200 18 YEARS N/A ONC GI: BILIARY

NCT01984996 USA INSIGHTRA DEVICE 2. RECRUITING NA 150 18 YEARS N/A GI HERNIA

NCT01997736 USA TORAY DEVICE 2. RECRUITING NA 3518

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT02000271 USA TRIHEALTH PROCEDURE 2. RECRUITING NA 10418

YEARS 85

YEARS B8338O&G PEL-VIC DISEASE

NCT02000310 USA O ALPAN 2. RECRUITING NA 30 N/A N/A ENDO METAB/NUTR

NCT02003404 USA HOLLISTER DEVICE 2. RECRUITING NA 2518

YEARS 80

YEARS DERM SCAR/INJURY

NCT02003521 USA MEDICAL ACOUSTICS

DEVICE 2. RECRUITING NA 4812

YEARS N/A

ALLERGY ASTHMA

NCT02003898 USA MEDTRONIC 2. RECRUITING NA 1,200 16 YEARS N/A ENDO DIABETES

Studies opening a first Site in a New Country, from Page 30

Page 32: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 32

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01295827 AUSTRALIA MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01683695 AUSTRALIA AMGEN DRUG 2. RECRUITING 1 4018

YEARS 65

YEARS RHEUM LUPUS ERYTHEM.

NCT01794507 AUSTRALIA ABBVIE DRUG 2. RECRUITING 1 3018

YEARS N/A

ONC HEM: MYELOMA

NCT01420081 AUSTRALIA PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01624142 AUSTRALIA AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01902290 AUSTRALIA AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01337089 AUSTRALIA GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 AUSTRALIA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01424566 AUSTRALIA GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01458951 AUSTRALIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01529034 AUSTRALIA UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01560624 AUSTRALIA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 AUSTRALIA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01697072 AUSTRALIA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01712490 AUSTRALIA MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01774786 AUSTRALIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01813422 AUSTRALIA AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01751022 AUSTRALIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01923181 AUSTRIA NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01939366 AUSTRIA GRENENTHAL DRUG 2. RECRUITING 2 35018

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT01345019 AUSTRIA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01458951 AUSTRIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01560624 AUSTRIA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 AUSTRIA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01697072 AUSTRIA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01774786 AUSTRIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 33)(Return to Page 1)

Studies opening additional Sites in a Country, from Page 31

Page 33: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 33

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01798485 AUSTRIA SYNTA DRUG 2. RECRUITING 3 50018

YEARS N/A ONC RESP: LUNG

NCT01860638 AUSTRIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01281293 AUSTRIA CYBERONICS 2. RECRUITING NA 600 7 YEARS N/A NEUR EPILEPSY/SEIZURE

NCT01751022 AUSTRIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01439971 BELGIUM PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01715909 BELGIUM HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01848834 BELGIUM MERCK DRUG 2. RECRUITING 1 11418

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01894256 BELGIUM ASTRAZENECA DRUG 2. RECRUITING 1 4218

YEARS 75

YEARS ONC SOLID TUMOR/CANCER

NCT01440374 BELGIUM GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01624142 BELGIUM AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01809340 BELGIUM JANSSEN DRUG 2. RECRUITING 2 7018

YEARS 80

YEARS PSYCH DEPRESSION

NCT01337089 BELGIUM GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01458951 BELGIUM PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01697072 BELGIUM AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01705574 BELGIUM GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01712490 BELGIUM MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01774786 BELGIUM HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 BELGIUM MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01798485 BELGIUM SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01813422 BELGIUM AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01957176 BELGIUM GSK DRUG 2. RECRUITING 4 100 1 YEAR N/A CARDIO THROMB/COAG

NCT01281293 BELGIUM CYBERONICS 2. RECRUITING NA 600 7 YEARS N/A NEUR EPILEPSY/SEIZURE

NCT01543503 BELGIUM HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01751022 BELGIUM MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01839526 BELGIUM GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25 YEARS ENDO FABRY

NCT01966471 BOSNIA AND HERZEGOVINA

HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 34)

Studies opening additional Sites in a Country, from Page 32

(Return to Page 1)

Page 34: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 34

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01798485 BOSNIA AND HERZEGOVINA

SYNTA DRUG 2. RECRUITING 3 50018

YEARS N/A ONC RESP: LUNG

NCT01860638 BOSNIA AND HERZEGOVINA

HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01992276 BRAZIL CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01939223 BRAZIL BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01705574 BRAZIL GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01774786 BRAZIL HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01860638 BRAZIL HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01992276 BULGARIA CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01439971 BULGARIA PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01923181 BULGARIA NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01270828 BULGARIA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01337089 BULGARIA GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 BULGARIA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01697072 BULGARIA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01774786 BULGARIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01860638 BULGARIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01930188 BULGARIA NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01992276 CANADA CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01966471 CANADA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01295827 CANADA MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01715909 CANADA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01357161 CANADA MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01420081 CANADA PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01440374 CANADA GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01624142 CANADA AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01902290 CANADA AMGEN BIOLOGICAL 2. RECRUITING 2 56618

YEARS 75

YEARS ALLERGY ASTHMA

NCT01923181 CANADA NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 35)

Studies opening additional Sites in a Country, from Page 33

(Return to Page 1)

Page 35: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 35

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01345019 CANADA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01458951 CANADA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01529034 CANADA UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01557244 CANADA PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01560624 CANADA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 CANADA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01608490 CANADA PNEUMRX DEVICE 2. RECRUITING 3 31535

YEARS N/A

RESP EMPHYSEMA

NCT01697072 CANADA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01712490 CANADA MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01774786 CANADA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 CANADA MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01813422 CANADA AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01860638 CANADA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01884675 CANADA GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01914757 CANADA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,026 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01962974 CANADA JANSSEN BIOLOGICAL 2. RECRUITING 3 20018

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01907854 CANADA NOVO NORDISK DRUG 2. RECRUITING 4 396 18 YEARS N/A ENDO DIABETES

NCT01751022 CANADA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01424566 CHILE GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01782131 CHILE MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01751022 CHILE MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01560624 CHINA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 CHINA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01270828 COLOMBIA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01458951 COLOMBIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01543503 COLOMBIA HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01774786 CROATIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 36)

Studies opening additional Sites in a Country, from Page 34

(Return to Page 1)

Page 36: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 36

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01798485 CROATIA SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01860638 CROATIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01885208 CROATIA NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01966471 CZECH REP HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01585766 CZECH REP MEDIMMUNE BIOLOGICAL 2. RECRUITING 1 2818

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT01440374 CZECH REP GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01624142 CZECH REP AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01919164 CZECH REP EMD SERONO DRUG 2. RECRUITING 2 54540

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01270828 CZECH REP PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01337089 CZECH REP GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 CZECH REP AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01458951 CZECH REP PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01697072 CZECH REP AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01712490 CZECH REP MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01798485 CZECH REP SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01813422 CZECH REP AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01510028 DENMARK SHIRE BIOLOGICAL 2. RECRUITING 1 18 N/A 12

YEARS NEUR LEUKO-DYSTROPHY

NCT01683695 DENMARK AMGEN DRUG 2. RECRUITING 1 4018

YEARS 65

YEARS RHEUM LUPUS ERYTHEM.

NCT01919164 DENMARK EMD SERONO DRUG 2. RECRUITING 2 54540

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01923181 DENMARK NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01925209 DENMARK NOVARTIS DRUG 2. RECRUITING 2 24036

YEARS 85

YEARS ORTH MUSCU-LAR DISEASE

NCT01939366 DENMARK GRENENTHAL DRUG 2. RECRUITING 2 35018

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT01458951 DENMARK PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01697072 DENMARK AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01701362 DENMARK PFIZER DRUG 2. RECRUITING 3 470 18 YEARS N/A NEUR NEURALGIA

NCT01712490 DENMARK MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01751022 DENMARK MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 37)

Studies opening additional Sites in a Country, from Page 35

(Return to Page 1)

Page 37: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 37

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01543503 ECUADOR HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01172548 EGYPT NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01774786 EL SALVADOR HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01919164 ESTONIA EMD SERONO DRUG 2. RECRUITING 2 54540

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01337089 ESTONIA GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01458951 ESTONIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01557244 ESTONIA PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01782131 ESTONIA MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01860638 ESTONIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01715909 FINLAND HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01557244 FINLAND PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01774786 FINLAND HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01992276 FRANCE CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01939223 FRANCE BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01295827 FRANCE MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01510028 FRANCE SHIRE BIOLOGICAL 2. RECRUITING 1 18 N/A 12

YEARS NEUR LEUKO-DYSTROPHY

NCT01683695 FRANCE AMGEN DRUG 2. RECRUITING 1 4018

YEARS 65

YEARS RHEUM LUPUS ERYTHEM.

NCT01894256 FRANCE ASTRAZENECA DRUG 2. RECRUITING 1 4218

YEARS 75

YEARS ONC SOLID TUMOR/CANCER

NCT01524978 FRANCE HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 2 10118

YEARS N/A

ONC HEM: MYELOMA

NCT01624142 FRANCE AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01902290 FRANCE AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01939366 FRANCE GRENENTHAL DRUG 2. RECRUITING 2 35018

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT01345019 FRANCE AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01424566 FRANCE GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01458951 FRANCE PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01560624 FRANCE UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 38)

Studies opening additional Sites in a Country, from Page 36

(Return to Page 1)

Page 38: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 38

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01560637 FRANCE UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01697072 FRANCE AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01705574 FRANCE GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01737398 FRANCE ISIS DRUG 2. RECRUITING 3 19518

YEARS 75

YEARS NEUR NEUROPATHY

NCT01813422 FRANCE AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01860638 FRANCE HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01966471 GEORGIA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01992276 GERMANY CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01894022 GERMANY GSK DRUG 1. PLANNING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01939223 GERMANY BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01974440 GERMANY JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01510028 GERMANY SHIRE BIOLOGICAL 2. RECRUITING 1 18 N/A 12

YEARS NEUR LEUKO-DYSTROPHY

NCT01715909 GERMANY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01357161 GERMANY MERCK DRUG 2. RECRUITING 2 12018

YEARS N/A

ONC O&G: OVARY

NCT01440374 GERMANY GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01524978 GERMANY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 2 10118

YEARS N/A

ONC HEM: MYELOMA

NCT01902290 GERMANY AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01923181 GERMANY NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01972776 GERMANY NOVARTIS DRUG 2. RECRUITING 2 122 35 YEARS 75 YEARS RESP COPD

NCT01114529 GERMANY NOVARTIS DRUG 2. RECRUITING 3 67618

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

NCT01270828 GERMANY PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01337089 GERMANY GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 GERMANY AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01458951 GERMANY PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01529034 GERMANY UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01560624 GERMANY UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 GERMANY UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 39)

Studies opening additional Sites in a Country, from Page 37

(Return to Page 1)

Page 39: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 39

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01608490 GERMANY PNEUMRX DEVICE 2. RECRUITING 3 315 35 YEARS N/A RESP EMPHYSEMA

NCT01697072 GERMANY AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01701362 GERMANY PFIZER DRUG 2. RECRUITING 3 470 18 YEARS N/A NEUR NEURALGIA

NCT01774786 GERMANY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 GERMANY MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01798485 GERMANY SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01856309 GERMANY JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01884675 GERMANY GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01885208 GERMANY NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01281293 GERMANY CYBERONICS 2. RECRUITING NA 600 7 YEARS N/A NEUR EPILEPSY/SEIZURE

NCT01543503 GERMANY HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01751022 GERMANY MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01806636 GERMANY PNEUMRX DEVICE 2. RECRUITING NA 1,00025

YEARS N/A

RESP EMPHYSEMA

NCT01953874 GERMANY RESMED DEVICE 2. RECRUITING NA 21521

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01440374 GREECE GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01624142 GREECE AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01902290 GREECE AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01345019 GREECE AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01697072 GREECE AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01813422 GREECE AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01860638 GREECE HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01885208 GREECE NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01543503 GREECE HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01774786 GUATEMALA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01543503 GUATEMALA HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01440374 HONG KONG GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01624142 HONG KONG AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

Studies opening additional Sites in a Country, from Page 38

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 40)(Return to Page 1)

Page 40: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 40

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01902290 HONG KONG AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01919164 HONG KONG EMD SERONO DRUG 2. RECRUITING 2 54540

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01270828 HONG KONG PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01345019 HONG KONG AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01930188 HONG KONG NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01966471 HUNGARY HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01439971 HUNGARY PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01357161 HUNGARY MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01440374 HUNGARY GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01337089 HUNGARY GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 HUNGARY AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01458951 HUNGARY PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01697072 HUNGARY AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01712490 HUNGARY MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01747915 HUNGARY PFIZER DRUG 2. RECRUITING 3 168 5 YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01774786 HUNGARY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01798485 HUNGARY SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01813422 HUNGARY AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01270828 INDIA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01424566 INDIA GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01959529 INDIA NOVO NORDISK DRUG 2. RECRUITING 3 7,500 50 YEARS N/A ENDO DIABETES

NCT01172548 INDIA NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01907854 INDIA NOVO NORDISK DRUG 2. RECRUITING 4 396 18 YEARS N/A ENDO DIABETES

NCT01751022 INDIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01440374 IRELAND GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01902290 IRELAND AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01345019 IRELAND AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01957176 IRELAND GSK DRUG 2. RECRUITING 4 100 1 YEAR N/A CARDIO THROMB/COAG

NCT01939223 ISRAEL BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

Studies opening additional Sites in a Country, from Page 39

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 41)(Return to Page 1)

Page 41: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 41

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01966471 ISRAEL HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01715909 ISRAEL HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01848834 ISRAEL MERCK DRUG 2. RECRUITING 1 11418

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01357161 ISRAEL MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01440374 ISRAEL GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01923181 ISRAEL NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01424566 ISRAEL GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01458951 ISRAEL PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01782131 ISRAEL MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01907854 ISRAEL NOVO NORDISK DRUG 2. RECRUITING 4 396 18 YEARS N/A ENDO DIABETES

NCT01939223 ITALY BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01295827 ITALY MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01439971 ITALY PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01715909 ITALY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01440374 ITALY GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01902290 ITALY AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01923181 ITALY NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01925209 ITALY NOVARTIS DRUG 2. RECRUITING 2 24036

YEARS 85

YEARS ORTH MUSCU-LAR DISEASE

NCT01939366 ITALY GRENENTHAL DRUG 2. RECRUITING 2 35018

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT01345019 ITALY AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01424566 ITALY GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01557244 ITALY PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01560624 ITALY UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 ITALY UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01697072 ITALY AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01705574 ITALY GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01712490 ITALY MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01737398 ITALY ISIS DRUG 2. RECRUITING 3 19518

YEARS 75

YEARS NEUR NEUROPATHY

Studies opening additional Sites in a Country, from Page 40

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 42)(Return to Page 1)

Page 42: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 42

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01774786 ITALY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01813422 ITALY AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01860638 ITALY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01885208 ITALY NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01948856 ITALY PIERRE FABRE DRUG 2. RECRUITING 3 1,000 3 YEARS 4 YEARS INFECT INFLUENZA/FLU

NCT01543503 ITALY HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01751022 ITALY MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01894022 JAPAN GSK DRUG 1. PLANNING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01966471 JAPAN HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01420081 JAPAN PFIZER DRUG 2. RECRUITING 2 144 20 YEARS N/A ONC O&G: UTERUS

NCT01624142 JAPAN AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01345019 JAPAN AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01557244 JAPAN PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01774786 JAPAN HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01884675 JAPAN GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01930188 JAPAN NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01172548 JORDAN NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01894022 KOREA, SOUTH GSK DRUG 1. PLANNING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01295827 KOREA, SOUTH MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01440374 KOREA, SOUTH GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01345019 KOREA, SOUTH AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01424566 KOREA, SOUTH GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01458951 KOREA, SOUTH PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01557244 KOREA, SOUTH PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01560624 KOREA, SOUTH UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 KOREA, SOUTH UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

Studies opening additional Sites in a Country, from Page 41

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 43)(Return to Page 1)

Page 43: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 43

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 44)

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01712490 KOREA, SOUTH MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM:LYMPHOMA

NCT01774786 KOREA, SOUTH HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 KOREA, SOUTH MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01813422 KOREA, SOUTH AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01884675 KOREA, SOUTH GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01337089 LATVIA GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01458951 LATVIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01860638 LATVIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01172548 LEBANON NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01337089 LITHUANIA GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01747915 LITHUANIA PFIZER DRUG 2. RECRUITING 3 168 5 YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01856309 LITHUANIA JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01860638 LITHUANIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01948856 LITHUANIA PIERRE FABRE DRUG 2. RECRUITING 3 1,000 3 YEARS 4 YEARS INFECT INFLUENZA/FLU

NCT01774786 MACEDONIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01683695 MALAYSIA AMGEN DRUG 2. RECRUITING 1 4018

YEARS 65

YEARS RHEUM LUPUS ERYTHEM.

NCT01345019 MALAYSIA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01557244 MALAYSIA PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01774786 MALAYSIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01813422 MALAYSIA AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01838044 MALAYSIA PFIZER DRUG 2. RECRUITING 4 366 18 YEARS 75 YEARS ORTH BACK PAIN

NCT01966471 MEXICO HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01440374 MEXICO GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01337089 MEXICO GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01371734 MEXICO PFIZER DRUG 2. RECRUITING 3 390 7 YEARS 17

YEARS PSYCH DEPRESSION

NCT01560624 MEXICO UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

Studies opening additional Sites in a Country, from Page 42

(Return to Page 1)

Page 44: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 44

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01560637 MEXICO UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01697072 MEXICO AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01705574 MEXICO GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01774786 MEXICO HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01813422 MEXICO AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01930188 MEXICO NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01959529 MEXICO NOVO NORDISK DRUG 2. RECRUITING 3 7,500 50 YEARS N/A ENDO DIABETES

NCT01543503 MEXICO HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01172548 MOROCCO NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01226316 NETHERLANDS ASTRAZENECA DRUG 2. RECRUITING 1 17018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01894256 NETHERLANDS ASTRAZENECA DRUG 2. RECRUITING 1 4218

YEARS 75

YEARS ONC SOLID TUMOR/CANCER

NCT01440374 NETHERLANDS GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01809340 NETHERLANDS JANSSEN DRUG 2. RECRUITING 2 7018

YEARS 80

YEARS PSYCH DEPRESSION

NCT01939366 NETHERLANDS GRENENTHAL DRUG 2. RECRUITING 2 35018

YEARS 80

YEARS ANEST PAIN CHRONIC

NCT01458951 NETHERLANDS PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01560624 NETHERLANDS UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 NETHERLANDS UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01608490 NETHERLANDS PNEUMRX DEVICE 2. RECRUITING 3 315 35 YEARS N/A RESP EMPHYSEMA

NCT01747915 NETHERLANDS PFIZER DRUG 2. RECRUITING 3 168 5 YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01774786 NETHERLANDS HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01813422 NETHERLANDS AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01751022 NETHERLANDS MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01439971 NEW ZEALAND PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01624142 NEW ZEALAND AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01902290 NEW ZEALAND AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01345019 NEW ZEALAND AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

Studies opening additional Sites in a Country, from Page 43

(See Studies opening additional Sites in a Country, Page 45)(Return to Page 1)

Page 45: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 45

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01458951 NEW ZEALAND PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01966471 NORWAY HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01295827 NORWAY MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01813422 NORWAY AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01930188 NORWAY NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01751022 NORWAY MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01839526 NORWAY GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25 YEARS ENDO FABRY

NCT01774786 PANAMA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01543503 PANAMA HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01966471 PERU HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01774786 PERU HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 PERU MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01966471 POLAND HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01585766 POLAND MEDIMMUNE BIOLOGICAL 2. RECRUITING 1 2818

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT01715909 POLAND HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01420081 POLAND PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01440374 POLAND GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01902290 POLAND AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01270828 POLAND PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01337089 POLAND GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 POLAND AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01458951 POLAND PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01557244 POLAND PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01697072 POLAND AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01712490 POLAND MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01774786 POLAND HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01798485 POLAND SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 46)(Return to Page 1)

Studies opening additional Sites in a Country, from Page 44

Page 46: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 46

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01813422 POLAND AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01939223 PORTUGAL BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01966471 PORTUGAL HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01345019 PORTUGAL AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01697072 PORTUGAL AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01705574 PORTUGAL GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01737398 PORTUGAL ISIS DRUG 2. RECRUITING 3 19518

YEARS 75

YEARS NEUR NEUROPATHY

NCT01860638 PORTUGAL HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01543503 PORTUGAL HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01966471 ROMANIA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01809340 ROMANIA JANSSEN DRUG 2. RECRUITING 2 7018

YEARS 80

YEARS PSYCH DEPRESSION

NCT01919164 ROMANIA EMD SERONO DRUG 2. RECRUITING 2 54540

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01337089 ROMANIA GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01458951 ROMANIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01697072 ROMANIA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01701362 ROMANIA PFIZER DRUG 2. RECRUITING 3 470 18 YEARS N/A NEUR NEURALGIA

NCT01774786 ROMANIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01798485 ROMANIA SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01930188 ROMANIA NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01751022 ROMANIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01894022 RUSSIA GSK DRUG 1. PLANNING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01357161 RUSSIA MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01420081 RUSSIA PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01440374 RUSSIA GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01902290 RUSSIA AMGEN BIOLOGICAL 2. RECRUITING 2 566 18 YEARS 75 YEARS ALLERGY ASTHMA

NCT01270828 RUSSIA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01345019 RUSSIA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01458951 RUSSIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

Studies opening additional Sites in a Country, from Page 45

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 47)(Return to Page 1)

Page 47: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 47

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01557244 RUSSIA PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01697072 RUSSIA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01705574 RUSSIA GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01774786 RUSSIA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01798485 RUSSIA SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01813422 RUSSIA AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01856309 RUSSIA JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01884675 RUSSIA GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01930188 RUSSIA NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01172548 RUSSIA NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01172548 SAUDI ARABIA NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01751022 SAUDI ARABIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01923181 SERBIA NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01270828 SERBIA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01798485 SERBIA SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01814748 SERBIA MERCK DRUG 2. RECRUITING 3 200 18 YEARS 44 YEARS ENDO DIABETES

NCT01885208 SERBIA NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01683695 SINGAPORE AMGEN DRUG 2. RECRUITING 1 4018

YEARS 65

YEARS RHEUM LUPUS ERYTHEM.

NCT01345019 SINGAPORE AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01782131 SINGAPORE MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01813422 SINGAPORE AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01838044 SINGAPORE PFIZER DRUG 2. RECRUITING 4 366 18 YEARS 75 YEARS ORTH BACK PAIN

NCT01420081 SLOVAKIA PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01270828 SLOVAKIA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01458951 SLOVAKIA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01557244 SLOVAKIA PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01697072 SLOVAKIA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01751022 SLOVAKIA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

Studies opening additional Sites in a Country, from Page 46

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 48)(Return to Page 1)

Page 48: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 48

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01966471 SOUTH AFRICA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01715909 SOUTH AFRICA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01624142 SOUTH AFRICA AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01923181 SOUTH AFRICA NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01270828 SOUTH AFRICA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01458951 SOUTH AFRICA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01557244 SOUTH AFRICA PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01697072 SOUTH AFRICA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01814748 SOUTH AFRICA MERCK DRUG 2. RECRUITING 3 200 18 YEARS 44 YEARS ENDO DIABETES

NCT01930188 SOUTH AFRICA NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01172548 SOUTH AFRICA NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01751022 SOUTH AFRICA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01992276 SPAIN CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01894022 SPAIN GSK DRUG 1. PLANNING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01939223 SPAIN BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01966471 SPAIN HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01295827 SPAIN MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01585766 SPAIN MEDIMMUNE BIOLOGICAL 2. RECRUITING 1 2818

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT01715909 SPAIN HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01420081 SPAIN PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01440374 SPAIN GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01524978 SPAIN HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 2 10118

YEARS N/A

ONC HEM: MYELOMA

NCT01624142 SPAIN AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01809340 SPAIN JANSSEN DRUG 2. RECRUITING 2 7018

YEARS 80

YEARS PSYCH DEPRESSION

NCT01923181 SPAIN NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01337089 SPAIN GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 SPAIN AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

Studies opening additional Sites in a Country, from Page 47

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 49)(Return to Page 1)

Page 49: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 49

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01424566 SPAIN GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01458951 SPAIN PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01529034 SPAIN UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01557244 SPAIN PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01697072 SPAIN AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01712490 SPAIN MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01774786 SPAIN HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 SPAIN MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01798485 SPAIN SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01813422 SPAIN AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01856309 SPAIN JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01860638 SPAIN HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01884675 SPAIN GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01930188 SPAIN NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01907854 SPAIN NOVO NORDISK DRUG 2. RECRUITING 4 396 18 YEARS N/A ENDO DIABETES

NCT01543503 SPAIN HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01751022 SPAIN MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01839526 SPAIN GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25 YEARS ENDO FABRY

NCT01974440 SWEDEN JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM:LYMPHOMA

NCT01357161 SWEDEN MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01923181 SWEDEN NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01270828 SWEDEN PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01557244 SWEDEN PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01697072 SWEDEN AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01701362 SWEDEN PFIZER DRUG 2. RECRUITING 3 470 18 YEARS N/A NEUR NEURALGIA

NCT01813422 SWEDEN AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01860638 SWEDEN HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01930188 SWEDEN NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01977014 SWEDEN NORDICINFU 2. RECRUITING NA 25 N/A N/A CARDIO HYPER-TENSION PULM

Studies opening additional Sites in a Country, from Page 48

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 50)(Return to Page 1)

Page 50: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 50

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01966471 SWITZERLAND HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01345019 SWITZERLAND AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01557244 SWITZERLAND PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01697072 SWITZERLAND AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01774786 SWITZERLAND HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 SWITZERLAND MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01885208 SWITZERLAND NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01543503 SWITZERLAND HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01751022 SWITZERLAND MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01357161 TAIWAN MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01440374 TAIWAN GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01270828 TAIWAN PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01345019 TAIWAN AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01424566 TAIWAN GW DRUG 2. RECRUITING 3 540 18 YEARS N/A ANEST PAIN

NCT01458951 TAIWAN PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01557244 TAIWAN PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01560624 TAIWAN UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 TAIWAN UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01712490 TAIWAN MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01774786 TAIWAN HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01856309 TAIWAN JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01172548 TAIWAN NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01440374 THAILAND GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01705574 THAILAND GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01774786 THAILAND HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01930188 THAILAND NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01172548 THAILAND NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

Studies opening additional Sites in a Country, from Page 49

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 51)(Return to Page 1)

Page 51: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 51

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01838044 THAILAND PFIZER DRUG 2. RECRUITING 4 366 18 YEARS 75 YEARS ORTH BACK PAIN

NCT01345019 TURKEY AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01557244 TURKEY PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01774786 TURKEY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01860638 TURKEY HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01930188 TURKEY NOVO NORDISK DRUG 2. RECRUITING 3 1,200 18 YEARS N/A ENDO DIABETES

NCT01172548 TURKEY NOVARTIS DRUG 2. RECRUITING 4 15018

YEARS N/A

ONC GI: GAS-TROINTESTINAL

NCT01705574 UGANDA GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01270828 UKRAINE PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01458951 UKRAINE PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01529034 UKRAINE UPSHER-SMITH

DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01697072 UKRAINE AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01798485 UKRAINE SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01543503 UKRAINE HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01974440 UK JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01226316 UK ASTRAZENECA DRUG 2. RECRUITING 1 17018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01295827 UK MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01439971 UK PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01585766 UK MEDIMMUNE BIOLOGICAL 2. RECRUITING 1 2818

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT01715909 UK HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01894256 UK ASTRAZENECA DRUG 2. RECRUITING 1 4218

YEARS 75

YEARS ONC SOLID TUMOR/CANCER

NCT01357161 UK MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01420081 UK PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01524978 UK HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 2 10118

YEARS N/A

ONC HEM: MYELOMA

NCT01923181 UK NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01972776 UK NOVARTIS DRUG 2. RECRUITING 2 122 35 YEARS 75 YEARS RESP COPD

NCT01337089 UK GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 UK AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

Studies opening additional Sites in a Country, from Page 50

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies opening additional Sites in a Country, Page 52)(Return to Page 1)

Page 52: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 52

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01557244 UK PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01560624 UK UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 UK UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01608490 UK PNEUMRX DEVICE 2. RECRUITING 3 315 35 YEARS N/A RESP EMPHYSEMA

NCT01697072 UK AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01705574 UK GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

NCT01712490 UK MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01737398 UK ISIS DRUG 2. RECRUITING 3 19518

YEARS 75

YEARS NEUR NEUROPATHY

NCT01798485 UK SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01856309 UK JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01860638 UK HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 51018

YEARS N/A

ONC CNS: GLIOMA

NCT01884675 UK GSK DRUG 2. RECRUITING 3 16018

YEARS 75

YEARS CARDIO HYPERTENSION

NCT01885208 UK NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01281293 UK CYBERONICS 2. RECRUITING NA 600 7 YEARS N/A NEUR EPILEPSY/SEIZURE

NCT01543503 UK HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01751022 UK MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01992276 USA CRUCELL BIOLOGICAL 1. PLANNING 2 26218

YEARS N/A

INFECT INFLUENZA/FLU

NCT01939223 USA BAYER DRUG 1. PLANNING 3 75018

YEARS N/A

ONC GI: COLORECTAL

NCT01966471 USA HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018

YEARS N/A ONC BREAST

NCT01974440 USA JANSSEN DRUG 1. PLANNING 3 40018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01295827 USA MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01439971 USA PFIZER BIOLOGICAL 2. RECRUITING 1 2418

YEARS 64

YEARS HEM HAEMOPHILIA A/B

NCT01546038 USA PFIZER DRUG 2. RECRUITING 1 26518

YEARS N/A

ONC HEM: LEUKEMIA

NCT01585766 USA MEDIMMUNE BIOLOGICAL 2. RECRUITING 1 2818

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT01683695 USA AMGEN DRUG 2. RECRUITING 1 4018

YEARS 65

YEARS RHEUM LUPUS ERYTHEM.

NCT01693562 USA MEDIMMUNE DRUG 2. RECRUITING 1 22018

YEARS N/A

ONC DERM: MELANOMA

Studies opening additional Sites in a Country, from Page 51

(See Studies opening additional Sites in a Country, Page 53)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

Page 53: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 53

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01715909 USA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 1 20 N/A 12

YEARS INFECT INFLUENZA/FLU

NCT01794507 USA ABBVIE DRUG 2. RECRUITING 1 3018

YEARS N/A

ONC HEM: MYELOMA

NCT01848834 USA MERCK DRUG 2. RECRUITING 1 11418

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01357161 USA MERCK DRUG 2. RECRUITING 2 120 18 YEARS N/A ONC O&G: OVARY

NCT01420081 USA PFIZER DRUG 2. RECRUITING 2 14420

YEARS N/A

ONC O&G: UTERUS

NCT01440374 USA GSK DRUG 2. RECRUITING 2 15018

YEARS N/A

CARDIO THROMB/COAG

NCT01524978 USA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 2 10118

YEARS N/A

ONC HEM: MYELOMA

NCT01624142 USA AMGEN DRUG 2. RECRUITING 2 25012

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01902290 USA AMGEN BIOLOGICAL 2. RECRUITING 2 56618

YEARS 75

YEARS ALLERGY ASTHMA

NCT01919164 USA EMD SERONO DRUG 2. RECRUITING 2 54540

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01923181 USA NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01925209 USA NOVARTIS DRUG 2. RECRUITING 2 24036

YEARS 85

YEARS ORTH MUSCU-LAR DISEASE

NCT00642616 USA MANNKIND DRUG 2. RECRUITING 3 510 18 YEARS N/A RESP COPD

NCT01270828 USA PFIZER DRUG 2. RECRUITING 3 800 18 YEARS N/A NEUR NEURALGIA

NCT01337089 USA GW DRUG 2. RECRUITING 3 760 18 YEARS N/A ANEST PAIN

NCT01345019 USA AMGEN DRUG 2. RECRUITING 3 1,52018

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01371734 USA PFIZER DRUG 2. RECRUITING 3 390 7 YEARS 17

YEARS PSYCH DEPRESSION

NCT01458951 USA PFIZER DRUG 2. RECRUITING 3 54518

YEARS N/A

GI ULCERATIVE COLITIS

NCT01529034 USA UPSHER-SMITH DRUG 2. RECRUITING 3 15514

YEARS 66

YEARS NEUR EPILEPSY/SEIZURE

NCT01543178 USA SALIX DRUG 2. RECRUITING 3 80018

YEARS N/A

GI IRRITABLE BOWEL

NCT01557244 USA PFIZER DRUG 2. RECRUITING 3 132 6 YEARS 16

YEARS UROLOGY INCONTINENCE

NCT01560624 USA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01560637 USA UNITED THERAPEUTICS

DRUG 2. RECRUITING 3 85818

YEARS 75

YEARS CARDIO HYPER-TENSION PULM

NCT01608490 USA PNEUMRX DEVICE 2. RECRUITING 3 31535

YEARS N/A

RESP EMPHYSEMA

NCT01697072 USA AMGEN DRUG 2. RECRUITING 3 45018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01701362 USA PFIZER DRUG 2. RECRUITING 3 470 18 YEARS N/A NEUR NEURALGIA

NCT01705574 USA GILEAD DRUG 2. RECRUITING 3 510 18 YEARS N/A INFECT HIV/AIDS

Studies opening additional Sites in a Country, from Page 52

(See Studies opening additional Sites in a Country, Page 54)

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

Page 54: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 54

iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01712490 USA MILLENNIUM DRUG 2. RECRUITING 3 1,04018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01737398 USA ISIS DRUG 2. RECRUITING 3 19518

YEARS 75

YEARS NEUR NEUROPATHY

NCT01747915 USA PFIZER DRUG 2. RECRUITING 3 168 5 YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01774786 USA HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 3 78018

YEARS N/A

ONC GI: ESOPHA-GEAL/GASTRIC

NCT01782131 USA MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01798485 USA SYNTA DRUG 2. RECRUITING 3 500 18 YEARS N/A ONC RESP: LUNG

NCT01813422 USA AMGEN DRUG 2. RECRUITING 3 95018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01814748 USA MERCK DRUG 2. RECRUITING 3 20018

YEARS 44

YEARS ENDO DIABETES

NCT01856309 USA JANSSEN DRUG 2. RECRUITING 3 2,16518

YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01885208 USA NOVO NORDISK DRUG 2. RECRUITING 3 798 18 YEARS N/A ENDO DIABETES

NCT01914757 USA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,02618

YEARS 75

YEARS ALLERGY ASTHMA

NCT01944839 USA OPHTHOTECH DRUG 2. RECRUITING 3 62250

YEARS N/A

OPHTHAL MACULAR DEGENERATION

NCT01953601 USA MERCK DRUG 2. RECRUITING 3 1,50050

YEARS 85

YEARS NEUR ALZHEIMER/DEMENT

NCT01959529 USA NOVO NORDISK DRUG 2. RECRUITING 3 7,50050

YEARS N/A ENDO DIABETES

NCT01962974 USA JANSSEN BIOLOGICAL 2. RECRUITING 3 20018

YEARS 85

YEARS RHEUM ARTHRITIS/GOUT

NCT01966614 USA SOPHIRIS DRUG 2. RECRUITING 3 44050

YEARS N/A

UROLOGY PROSTATE HYPERPLASIA

NCT01968031 USA KYOWA DRUG 2. RECRUITING 3 60930

YEARS N/A NEUR PARKINSON

NCT01907854 USA NOVO NORDISK DRUG 2. RECRUITING 4 39618

YEARS N/A ENDO DIABETES

NCT01281293 USA CYBERONICS 2. RECRUITING NA 600 7 YEARS N/A NEUR EPILEPSY/SEIZURE

NCT01727297 USA MEDTRONIC DEVICE 2. RECRUITING NA 45018

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01735188 USA ALEXION OTHER 2. RECRUITING NA 30 N/A N/A ENDO INBORN ERROR

NCT01751022 USA MEDTRONIC DEVICE 2. RECRUITING NA 1,21018

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01757665 USA EDWARDS DEVICE 2. RECRUITING NA 65018

YEARS N/A CARDIO VALVE

NCT01839526 USA GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25 YEARS ENDO FABRY

NCT01543503 URUGUAY HOFFMANN-LA ROCHE

2. RECRUITING NA 1,18618

YEARS N/A

RHEUM ARTHRITIS/GOUT

Studies opening additional Sites in a Country, from Page 53

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

Page 55: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 55

(Return to Page 1)

COUNTRY

STUDIES OPENING A FIRST SITE

IN A NEW COUNTRY

STUDIES OPENING

ADDITIONAL SITES IN A COUNTRY

TOTAL TRIALS

ALBANIA 0 1 1

ALGERIA 1 1 2

ARGENTINA 8 6 14

AUSTRALIA 10 20 30

AUSTRIA 6 12 18

BELGIUM 10 21 31

BOSNIA AND HERZEGOVINA

0 3 3

BRAZIL 7 5 12

BULGARIA 3 10 13

CANADA 14 28 42

CHILE 3 3 6

CHINA 10 2 12

COLOMBIA 1 3 4

CROATIA 3 4 7

CZECH REPUBLIC 4 13 17

DENMARK 7 11 18

DOMINICAN REPUBLIC

1 0 1

ECUADOR 0 1 1

EGYPT 0 1 1

EL SALVADOR 0 1 1

ESTONIA 2 6 8

FINLAND 3 3 6

FRANCE 21 20 41

GEORGIA 0 1 1

GERMANY 21 34 55

GREECE 3 9 12

GUATEMALA 0 2 2

HONG KONG 1 7 8

HUNGARY 7 13 20

INDIA 3 6 9

IRELAND 0 4 4

ISRAEL 10 11 21

ITALY 12 25 37

JAPAN 10 9 19

JORDAN 0 1 1

KOREA, SOUTH 6 14 20

STuDy SiTeS by CouNTryThis table lists all countries with first-time and additional study sites that launched in the past week.

COUNTRY

STUDIES OPENING A FIRST SITE

IN A NEW COUNTRY

STUDIES OPENING

ADDITIONAL SITES IN A COUNTRY

TOTAL TRIALS

LATVIA 1 3 4

LEBANON 0 1 1

LITHUANIA 3 5 8

MACEDONIA 0 1 1

MALAYSIA 3 6 9

MEXICO 5 13 18

MOLDOVA, REPUBLIC OF

1 0 1

MOROCCO 0 1 1

NETHERLANDS 10 13 23

NEW ZEALAND 3 5 8

NORWAY 3 6 9

PANAMA 1 2 3

PERU 1 3 4

PHILIPPINES 1 0 1

POLAND 14 16 30

PORTUGAL 1 8 9

ROMANIA 4 11 15

RUSSIA 7 18 25

SAUDI ARABIA 0 2 2

SERBIA 2 5 7

SINGAPORE 0 5 5

SLOVAKIA 2 6 8

SLOVENIA 3 0 3

SOUTH AFRICA 4 12 16

SPAIN 14 33 47

SWEDEN 4 11 15

SWITZERLAND 4 9 13

TAIWAN 9 13 22

THAILAND 2 6 8

TUNISIA 1 0 1

TURKEY 5 6 11

UGANDA 0 1 1

UKRAINE 4 6 10

UNITED KINGDOM 18 30 48

UNITED STATES 57 61 118

URUGUAY 0 1 1

Page 56: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 56

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01949285 NEUROENABLING DEVICE 1. PLANNING 0 24 21 YEARS 65 YEARS ORTH SPINAL CORD INJURY

NCT01728207 IMMUNOMEDICS DRUG 1. PLANNING 1 50 18 YEARS N/A ONC HEM: LYMPHOMA

NCT01748864 ENDOCYTE DRUG 1. PLANNING 1 10 18 YEARS N/A HEALTHY/PHARM

NCT01771159 URO-RESEARCH DEVICE 1. PLANNING 1 10 18 YEARS N/A ORTH SPINAL CORD INJURY

NCT01792102 ONCOTHERA-PEUTICS

DRUG 1. PLANNING 1 38 18 YEARS N/A ONC HEM: MYELOMA

NCT01800175 OCULAR THERAPEUTIX

DEVICE 1. PLANNING 1 60 40 YEARS N/A HEALTHY/PHARM

NCT01803399 GSK DRUG 1. PLANNING 1 40 18 YEARS 65 YEARS INFECT BACTERIAL

NCT01805024 SANTHERA DRUG 1. PLANNING 1 24 5 YEARS 16 YEARS NEUR MUSCULAR DYSTROPHY

NCT01812382 GSK DRUG 1. PLANNING 1 3 18 YEARS 55 YEARS INFECT BACTERIAL

NCT01818869 ASTRAZENECA DRUG 1. PLANNING 1 24 18 YEARS 50 YEARS HEALTHY/PHARM

NCT01852825 MERCK BIOLOGICAL 1. PLANNING 1 34 18 YEARS 55 YEARS ALLERGY RHINITIS

NCT01870037 ION DRUG 1. PLANNING 1 18 18 YEARS N/A UROLOGY INCONTINENCE

NCT01870102 DAEWON DRUG 1. PLANNING 1MISS-ING

20 YEARS 40 YEARS HEALTHY/PHARM

NCT01877382 DAIICHI SANKYO DRUG 1. PLANNING 1 21 18 YEARS N/A ONC SOLID TUMOR/CANCER

NCT01879722 TAKEDA DRUG 1. PLANNING 1 60 18 YEARS 55 YEARS PSYCH SCHIZOPHRENIA

NCT01881789 ONYX DRUG 1. PLANNING 1 59 18 YEARS N/A ONC HEM: MYELOMA

NCT01882296 AHN-GOOK DRUG 1. PLANNING 1 40 20 YEARS 45 YEARS HEALTHY/PHARM

NCT01895946 ASTRAZENECA DRUG 1. PLANNING 1 24 18 YEARS N/A ONC SOLID TUMOR/CANCER

NCT01896323 CELGENE DRUG 1. PLANNING 1 14 18 YEARS 65 YEARS HEALTHY/PHARM

NCT01899703 GSK DRUG 1. PLANNING 1 40 18 YEARS 75 YEARS GI LIVER CIRRHOSIS

NCT01900522 TAKEDA DRUG 1. PLANNING 1 64 18 YEARS N/A PSYCH SCHIZOPHRENIA

NCT01902550 JANSSEN DRUG 1. PLANNING 1 12 18 YEARS 45 YEARS HEALTHY/PHARM

NCT01906307 LA JOLLA DRUG 1. PLANNING 1 15 18 YEARS N/A GI LIVER FAILURE

NCT01918202 PFIZER DRUG 1. PLANNING 1 12 21 YEARS 55 YEARS HEALTHY/PHARM

NCT01922050 LEO DRUG 1. PLANNING 1 588 18 YEARS N/A DERM KERATOSIS

NCT01924091 PARTNERSHIP MICROBICIDES

DRUG 1. PLANNING 1MISS-ING

18 YEARS N/A HEALTHY/PHARM

STuDieS uNDer plaNNiNG

This table lists all registered studies that are still under planning, have no site location listed and was first registered during the past year. About 10% of the studies listed as in the planning stage are replaced each week.

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 57)(Return to Page 1)

Page 57: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 57

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01924650 PFIZER DRUG 1. PLANNING 1 24 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01926002 MERCK DRUG 1. PLANNING 1 16 18 YEARS 55 YEARS ALLERGY ASTHMA

NCT01928862 FERRING DRUG 1. PLANNING 1 75 9 YEARS 16 YEARS GI COLON CLEANSING

NCT01929746 BIOGEN BIOLOGICAL 1. PLANNING 1 56 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01934647 MERCK DRUG 1. PLANNING 1 20 18 YEARS 70 YEARS CARDIO HYPER-TENSION PULM

NCT01937702 PROFIL OTHER 1. PLANNING 1 80 18 YEARS 74 YEARS ENDO DIABETES

NCT01937715 PFIZER DRUG 1. PLANNING 1 180 18 YEARS N/A ONC GI: COLORECTAL

NCT01938456 GSK DRUG 1. PLANNING 1 6 20 YEARS N/A ONC RESP: LUNG

NCT01940510 HOFFMANN-LA ROCHE

DRUG 1. PLANNING 1 22 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01943851 GSK DRUG 1. PLANNING 1 70 18 YEARS N/A ONC SOLID TUMOR/CANCER

NCT01947920 JANSSEN DRUG 1. PLANNING 1 30 18 YEARS 45 YEARS HEALTHY/PHARM

NCT01950364 MILLENNIUM DRUG 1. PLANNING 1 20 18 YEARS 75 YEARS ONC HEM: LYMPHOMA

NCT01950481 NOVARTIS DRUG 1. PLANNING 1 32 18 YEARS 70 YEARS GI LIVER DISEASE

NCT01952561 PARTNERSHIP MICROBICIDES

DRUG 1. PLANNING 1 40 18 YEARS 40 YEARS HEALTHY/PHARM

NCT01953341 AMGEN DRUG 1. PLANNING 1 80 18 YEARS 55 YEARS NEUR MIGRAINE/ H-ACHE

NCT01953783 MILLENNIUM DRUG 1. PLANNING 1 6 18 YEARS N/A ONC SOLID TUMOR/CANCER

NCT01953809 GSK DRUG 1. PLANNING 1 24 18 YEARS 45 YEARS INFECT BACTERIAL

NCT01954043 GSK DRUG 1. PLANNING 1 16 18 YEARS N/A ONC SOLID TUMOR/CANCER

NCT01955629 SANOFI DRUG 1. PLANNING 1 90 18 YEARS N/A ONC GI: COLORECTAL

NCT01962454 GSK DRUG 1. PLANNING 1 20 60 YEARS 75 YEARS ENDO MALNUTRITION

NCT01962792 PHARMACYCLICS DRUG 1. PLANNING 1 176 18 YEARS N/A ONC HEM: MYELOMA

NCT01965600 PFIZER DRUG 1. PLANNING 1 36 18 YEARS 45 YEARS HEALTHY/PHARM

NCT01966055 CEMPRA DRUG 1. PLANNING 1 8 12 YEARS 17 YEARS INFECT BACTERIAL

NCT01970865 PFIZER DRUG 1. PLANNING 1 200 18 YEARS N/A ONC RESP: LUNG

NCT01974349 ASTRAZENECA DRUG 1. PLANNING 1 34 18 YEARS 45 YEARS ONC SOLID TUMOR/CANCER

NCT01978301 GSK DRUG 1. PLANNING 1 30 18 YEARS 55 YEARS DERM SKIN DISEASE

NCT01978652 BIOGEN BIOLOGICAL 1. PLANNING 1 44 20 YEARS 45 YEARS HEALTHY/PHARM

NCT01980940 MERCK DRUG 1. PLANNING 1 68 40 YEARS N/A RHEUM ARTHRITIS/GOUT

NCT01983358 JEIL DRUG 1. PLANNING 1 56 19 YEARS 55 YEARS CARDIO STROKE

NCT01984047 GSK DRUG 1. PLANNING 1 48 18 YEARS 65 YEARS GI ULCERATIVE COLITIS

Studies under planning, from Page 56

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 58)(Return to Page 1)

Page 58: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 58

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01986010 MERCK BIOLOGICAL 1. PLANNING 1 142 18 YEARS N/A INFECT CYTOMEGALOVIRUS

NCT01986218 BMS DRUG 1. PLANNING 1 40 18 YEARS N/A ONC SOLID TUMOR/CANCER

NCT01989143 PFIZER DRUG 1. PLANNING 1 92 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01994668 PFIZER DRUG 1. PLANNING 1 8 20 YEARS 55 YEARS HEALTHY/PHARM

NCT01997905 ATRICURE DEVICE 1. PLANNING 1 30 18 YEARS 80 YEARS CARDIO ARRHYT/FIBRILL

NCT01999842 GSK BIOLOGICAL 1. PLANNING 1 420 18 YEARS 64 YEARS INFECT INFLUENZA/FLU

NCT01999972 PFIZER DRUG 1. PLANNING 1 65 18 YEARS N/A ONC SOLID TUMOR/CANCER

NCT01769027 CNS ONLUS DRUG 1. PLANNING 2 30 4 YEARS 40 YEARS PSYCH OBSESSIVE-COMPULSIVE

NCT01798121 JHP BIOLOGICAL 1. PLANNING 2 90 18 YEARS 60 YEARS INFECT TBC

NCT01798745 JANSSEN DRUG 1. PLANNING 2 110 18 YEARS N/A CARDIO CARDIO-MYOP/FAILURE

NCT01850004 BMS DRUG 1. PLANNING 2 75 18 YEARS N/A ONC HEM: LEUKEMIA

NCT01857232 ACACIA PHARMA LTD

DRUG 1. PLANNING 2 315 18 YEARS N/A ONC CHEMOTHER EFFECTS

NCT01889797 PRECOG BIOLOGICAL 1. PLANNING 2 150 18 YEARS N/A ONC HEM: LYMPHOMA

NCT01899833 CELL>POINT RADIATION 1. PLANNING 2 60 18 YEARS N/A CARDIO CORO-NARY/ISCHEMIC

NCT01908192 SYNEURX DRUG 1. PLANNING 2 126 12 YEARS 16 YEARS PSYCH SCHIZOPHRENIA

NCT01912196 MSI DRUG 1. PLANNING 2 286 21 YEARS 70 YEARS PSYCH DEPRESSION

NCT01915472 IMMUNOMEDICS DRUG 1. PLANNING 2 50 18 YEARS N/A ONC GI: COLORECTAL

NCT01915940 FORSIGHT DRUG 1. PLANNING 2 126 18 YEARS N/A OPHTHAL GLAUCOMA

NCT01925261 ORTHOTROPHIX DRUG 1. PLANNING 2 120 25 YEARS 75 YEARS RHEUM ARTHRITIS/GOUT

NCT01925950 SOLIGENIX DRUG 1. PLANNING 2 40 18 YEARS N/A IMMUNE GRAFT VS. HOST

NCT01927913 SHIRE DRUG 1. PLANNING 2 50 18 YEARS N/A HEM IRON OVERLOAD

NCT01933061 CELGENE DRUG 1. PLANNING 2 80 18 YEARS N/A ONC DERM: MELANOMA

NCT01934192 GSK DRUG 1. PLANNING 2 150 18 YEARS 85 YEARS GI PARESIS

NCT01945281 MERCK DRUG 1. PLANNING 2 90 N/A 3

MONTHS INFECT CANDIDIA

NCT01946477 CELGENE DRUG 1. PLANNING 2 85 18 YEARS N/A ONC HEM: MYELOMA

NCT01953536 MERCK DRUG 1. PLANNING 2 102 18 YEARS N/A ONC BREAST

Studies under planning, from Page 57

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 59)(Return to Page 1)

Page 59: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 59

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01955707 BIOGEN BIOLOGICAL 1. PLANNING 2 200 18 YEARS 85 YEARS CARDIO STROKE

NCT01956669 GSK DRUG 1. PLANNING 2 154 1 YEAR 18 YEARS ONC SOLID TUMOR/CANCER

NCT01957410 JANSSEN DRUG 1. PLANNING 2 32 18 YEARS 64 YEARS PSYCH DEPRESSION

NCT01961882 OTSUKA DRUG 1. PLANNING 2MISS-ING

60 YEARS N/A ONC HEM: LEUKEMIA

NCT01965613 XBIOTECH BIOLOGICAL 1. PLANNING 2 10 18 YEARS N/A INFECT BACTERIAL

NCT01967251 TAKEDA DRUG 1. PLANNING 2 950 45 YEARS N/A UROLOGY ERECTILE

NCT01970501 ARCA DRUG 1. PLANNING 2 620 18 YEARS N/A CARDIO ARRHYT/FIBRILL

NCT01972178 PRONOVA DRUG 1. PLANNING 2 140 18 YEARS 79 YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01972217 ASTRAZENECA DRUG 1. PLANNING 2 170 18 YEARS N/A ONC UROLOGY: PROSTATE

NCT01978236 GSK DRUG 1. PLANNING 2 30 18 YEARS N/A ONC DERM: MELANOMA

NCT01979614 NOVARTIS DRUG 1. PLANNING 2 60 18 YEARS N/A CARDIO CORO-NARY/ISCHEMIC

NCT01981811 OTSUKA DRUG 1. PLANNING 2 60 18 YEARS 55 YEARS PSYCH BIPOLAR

NCT01982292 NOVARTIS DRUG 1. PLANNING 2 300 18 YEARS N/A CARDIO CARDIO-MYOP/FAILURE

NCT01982318 TISSUETHERAPIES

DRUG 1. PLANNING 2 250 18 YEARS N/A DERM WOUND/ULCER

NCT01984242 HOFFMANN-LA ROCHE

DRUG 1. PLANNING 2 150 18 YEARS N/A ONC UROLOGY: KIDNEY

NCT01988961 JANSSEN BIOLOGICAL 1. PLANNING 2 100 18 YEARS N/A GI ULCERATIVE COLITIS

NCT01990859 BMS BIOLOGICAL 1. PLANNING 2 18 20 YEARS N/A ONC DERM: MELANOMA

NCT01994291 PFIZER DRUG 1. PLANNING 2 200 18 YEARS N/A OPHTHAL MACU-LAR EDEMA

NCT01995071 ABBVIE DRUG 1. PLANNING 2 80 18 YEARS 70 YEARS INFECT HEPATITIS C

NCT01995487 MEDINOL DEVICE 1. PLANNING 2 1906 18 YEARS N/A CARDIO CORO-NARY/ISCHEMIC

NCT01995500 MEDINOL DEVICE 1. PLANNING 2 300 18 YEARS N/A CARDIO CORO-NARY/ISCHEMIC

NCT01998828 GILEAD DRUG 1. PLANNING 2 80 18 YEARS N/A HEM POLYCYTHE-MIA VERA

NCT01753180 MATRIZYME BIOLOGICAL 1. PLANNING 3MISS-ING

18 YEARS 80 YEARS CARDIO PERIPH VASC

NCT01762644 PERLE DRUG 1. PLANNING 3 60 8 YEARS 60 YEARS ENDO DIABETES

NCT01762657 PERLE DRUG 1. PLANNING 3 60 8 YEARS 60 YEARS ENDO DIABETES

NCT01803646 AURIS DRUG 1. PLANNING 3 330 18 YEARS 75 YEARS ENT TINNITUS

NCT01815424 PFIZER DRUG 1. PLANNING 3 264 18 YEARS N/A DERM PSORIASIS

Studies under planning, from Page 58

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 60)(Return to Page 1)

Page 60: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 60

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01829347 VITAL THER. BIOLOGICAL 1. PLANNING 3 120 18 YEARS N/A GI LIVER FAILURE

NCT01838551 CORTENDO DRUG 1. PLANNING 3 90 18 YEARS N/A ENDO CUSHING

NCT01863680 MERCK SERONO DRUG 1. PLANNING 3 130 20 YEARS 45 YEARS O&G INFERTILITY

NCT01868048 GW DRUG 1. PLANNING 3 300 18 YEARS N/A NEUR SPASTICITY/PALSY

NCT01870362 CD PHARMA INDIA

DRUG 1. PLANNING 3 30 25 YEARS 60 YEARS DENTAL PERIODONTITIS

NCT01875874 VITAL THER. DRUG 1. PLANNING 3 126 18 YEARS 65 YEARS GI LIVER FAILURE

NCT01877668 PFIZER DRUG 1. PLANNING 3 400 18 YEARS N/A RHEUM ARTHRITIS/GOUT

NCT01879410 GSK DRUG 1. PLANNING 3 710 40 YEARS N/A RESP COPD

NCT01882712 GALDERMA DRUG 1. PLANNING 3 84 18 YEARS N/A DERM ROSACEA

NCT01884311 BIO BIOLOGICAL 1. PLANNING 3 45 2 YEARS 75 YEARS IMMUNE DISEASE

NCT01888484 OCTAPHARMA BIOLOGICAL 1. PLANNING 3 64 2 YEARS 75 YEARS IMMUNE IMMUNO-DEFICIENCY

NCT01890122 TAKEDA DRUG 1. PLANNING 3 640 18 YEARS 75 YEARS ENDO DIABETES

NCT01890798 GSK DRUG 1. PLANNING 3 55 5 YEARS N/A NEUR MUSCULAR DYSTROPHY

NCT01892345 ALEXION DRUG 1. PLANNING 3 132 18 YEARS N/A OPHTHAL OPTIC NERV DISEASE

NCT01898520 GW DRUG 1. PLANNING 3 72 8 YEARS 18 YEARS NEUR SPASTICITY/PALSY

NCT01899742 GSK DRUG 1. PLANNING 3 666 40 YEARS N/A RESP COPD

NCT01911364 CHIESI DRUG 1. PLANNING 3 3686 40 YEARS N/A RESP COPD

NCT01911858 BBRAUN MEDICAL

DEVICE 1. PLANNING 3 40 18 YEARS N/A DERM BURNS

NCT01912456 CSL BEHRING BIOLOGICAL 1. PLANNING 3 80 12 YEARS N/A DERM ANGIOEDEMA

NCT01913353 BAVARIAN NORDIC

BIOLOGICAL 1. PLANNING 3MISS-ING

18 YEARS 40 YEARS HEALTHY/PHARM

NCT01913405 BAXTER BIOLOGICAL 1. PLANNING 3 30 12 YEARS 65 YEARS HEM HAEMOPHILIA A/B

NCT01917331 CHIESI DRUG 1. PLANNING 3 1863 40 YEARS N/A RESP COPD

NCT01929317 GSK DRUG 1. PLANNING 3 80 20 YEARS N/A NEUR PARKINSON

NCT01934010 AURIS DRUG 1. PLANNING 3 330 18 YEARS 76 YEARS ENT TINNITUS

NCT01934140 GSK BIOLOGICAL 1. PLANNING 3 400 17 YEARS 66 YEARS INFECT MENINGOCOCCAL

NCT01938144 PFIZER DRUG 1. PLANNING 3 750 18 YEARS N/A INFECT INFLUENZA/FLU

NCT01940887 OPHTHOTECH DRUG 1. PLANNING 3 622 50 YEARS N/A OPHTHAL MACULAR DEGENERATION

NCT01941004 NOVARTIS DRUG 1. PLANNING 3 132 18 YEARS 50 YEARS NEUR MULTIPLE SCLEROSIS

NCT01954394 SANOFI DRUG 1. PLANNING 3 1200 18 YEARS N/A CARDIO CHOLES-TEROL/LIPIDS

Studies under planning, from Page 59

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 61)(Return to Page 1)

Page 61: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 61

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01956812 IMMUNOMEDICS DRUG 1. PLANNING 3 440 18 YEARS N/A ONC GI: PANCREAS

NCT01957163 GSK DRUG 1. PLANNING 3 600 40 YEARS N/A RESP COPD

NCT01957722 AESCULAP PROCEDURE 1. PLANNING 3 233 18 YEARS 55 YEARS ORTH JOINT DISEASE

NCT01963143 BIO BIOLOGICAL 1. PLANNING 3 48 2 YEARS 55 YEARS IMMUNE DISEASE

NCT01964391 HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 127 18 YEARS N/A ONC BREAST

NCT01964560 UCB DRUG 1. PLANNING 3 500 1 MONTH 18 YEARS NEUR EPILEPSY/SEIZURE

NCT01964716 PFIZER BIOLOGICAL 1. PLANNING 3 500 42 DAYS 70 DAYS INFECT PNEUMOCOCCAL

NCT01968005 IL PHARMA DRUG 1. PLANNING 3 224 14 YEARS N/A ORTH BACK PAIN

NCT01970371 ACHAOGEN DRUG 1. PLANNING 3 360 18 YEARS 85 YEARS INFECT PNEUMONIA

NCT01972529 EISAI DRUG 1. PLANNING 3 300 18 YEARS N/A CARDIO THROMB/COAG

NCT01973049 BMS DRUG 1. PLANNING 3 200 18 YEARS N/A INFECT HEPATITIS C

NCT01973790 ZERIA DRUG 1. PLANNING 3 350 18 YEARS N/A GI DYSPEPSIA

NCT01975298 TEVA DRUG 1. PLANNING 3 600 18 YEARS 55 YEARS NEUR MULTIPLE SCLEROSIS

NCT01976104 EISAI DRUG 1. PLANNING 3 300 18 YEARS N/A CARDIO THROMB/COAG

NCT01976364 PFIZER DRUG 1. PLANNING 3 700 18 YEARS N/A RHEUM ARTHRITIS/GOUT

NCT01976728 FERRING DRUG 1. PLANNING 3 42 18 YEARS 40 YEARS ENDO MALE HYPOGONADISM

NCT01978093 GSK BIOLOGICAL 1. PLANNING 3 600 6 WEEKS 12 WEEKS INFECT NEISSERIA

NCT01978938 TETRAPHASE DRUG 1. PLANNING 3 840 18 YEARS N/A INFECT URINARY

NCT01979510 MERCK DRUG 1. PLANNING 3 100 18 YEARS 75 YEARS ORTH BACK PAIN

NCT01979939 BMS DRUG 1. PLANNING 3 400 18 YEARS N/A INFECT HEPATITIS C

NCT01980875 GILEAD DRUG 1. PLANNING 3 176 65 YEARS N/A ONC HEM: LEUKEMIA

NCT01980888 GILEAD DRUG 1. PLANNING 3 280 18 YEARS N/A ONC HEM: LEUKEMIA

NCT01982916 AHN-GOOK DRUG 1. PLANNING 3 330 12 YEARS N/A ALLERGY RHINITIS

NCT01983683 ACTELION DRUG 1. PLANNING 3 640 18 YEARS N/A INFECT ENTERITIS

NCT01984684 MELINTA DRUG 1. PLANNING 3 660 18 YEARS N/A INFECT SKIN/SOFT TISSUE

NCT01984697 MERCK BIOLOGICAL 1. PLANNING 3 1500 9 YEARS 26 YEARS INFECT PAPILLOMAVIRUS

NCT01986855 MERCK DRUG 1. PLANNING 3 468 25 YEARS N/A ENDO DIABETES

NCT01987895 ACTELION DRUG 1. PLANNING 3 640 18 YEARS N/A INFECT ENTERITIS

NCT01987960 H LUNDBECK DRUG 1. PLANNING 3 592 18 YEARS 65 YEARS PSYCH STRESS/PTSD

NCT01988857 GSK BIOLOGICAL 1. PLANNING 3 300 6 YEARS 10 YEARS INFECT DIPHTHERIA

NCT01989468 NOVARTIS BIOLOGICAL 1. PLANNING 3 405 18 YEARS N/A RHEUM ARTHRITIS/GOUT

NCT01990469 LG LIFE DRUG 1. PLANNING 3 174 19 YEARS N/A ENDO DIABETES

Studies under planning, from Page 60

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 62)(Return to Page 1)

Page 62: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 62

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01991795 ASTRAZENECA DRUG 1. PLANNING 3 17000 50 YEARS N/A ENDO DIABETES

NCT01992549 OCTAPHARMA BIOLOGICAL 1. PLANNING 3 100 N/A N/A HEM HAEMOPHILIA A/B

NCT01994889 PFIZER DRUG 1. PLANNING 3 400 18 YEARS 90 YEARS NEUR AMYLOIDOSIS

NCT01995266 BMS DRUG 1. PLANNING 3 150 18 YEARS N/A INFECT HEPATITIS C

NCT01996319 NOVARTIS DRUG 1. PLANNING 3 150 40 YEARS N/A RESP COPD

NCT01996865 CELGENE DRUG 1. PLANNING 3 500 18 YEARS N/A ONC HEM: LYMPHOMA

NCT01997229 ALEXION BIOLOGICAL 1. PLANNING 3 92 18 YEARS N/A NEUR MYASTHENIA GRAVIS

NCT01997268 SANCILIO DRUG 1. PLANNING 3 320 18 YEARS N/A CARDIO CHOLES-TEROL/LIPIDS

NCT01999218 MERCK DRUG 1. PLANNING 3 1230 18 YEARS N/A ENDO DIABETES

NCT01999673 PEREGRINE BIOLOGICAL 1. PLANNING 3 582 18 YEARS N/A ONC RESP: LUNG

NCT01770223 MERCK DRUG 1. PLANNING 4 100 18 YEARS N/A INFECT HEPATITIS C

NCT01790828 PFIZER DRUG 1. PLANNING 4 600 N/A N/A HEM HAEMOPHILIA A/B

NCT01793142 PFIZER DRUG 1. PLANNING 4 3000 19 YEARS N/A ENDO OSTEOPOROSIS

NCT01816672 CYTOMEDIX DEVICE 1. PLANNING 4 280 18 YEARS N/A ENDO DIABETES FOOT

NCT01819142 CYTOMEDIX DEVICE 1. PLANNING 4 400 18 YEARS N/A DERM WOUND/ULCER

NCT01824576 ADVANCED CIRCULATORY

DEVICE 1. PLANNING 4 10 18 YEARS N/A NEUR HEAD INJURY/TRAUMA

NCT01834937 INSIGHTEC DEVICE 1. PLANNING 4 50 18 YEARS N/A ONC CANCER PAIN/CACHEXIA

NCT01841437 GLAUKOS DEVICE 1. PLANNING 4 500 N/A N/A OPHTHAL GLAUCOMA

NCT01841450 GLAUKOS DEVICE 1. PLANNING 4 360 22 YEARS N/A OPHTHAL GLAUCOMA

NCT01848210 TAKEDA DRUG 1. PLANNING 4 336 18 YEARS 75 YEARS DERM WOUND/ULCER

NCT01863849 OMNINVEST BIOLOGICAL 1. PLANNING 4 120 18 YEARS N/A INFECT INFLUENZA/FLU

NCT01870843 XIAN-JANSSEN DRUG 1. PLANNING 4 260 18 YEARS 65 YEARS PSYCH DEPRESSION

NCT01884350 BMS DRUG 1. PLANNING 4 1112 18 YEARS N/A CARDIO ARRHYT/FIBRILL

NCT01887483 DANISCO DIETARY SUP.

1. PLANNING 4 230 18 YEARS 65 YEARS GI IRRITABLE BOWEL

NCT01896479 EXELIXIS DRUG 1. PLANNING 4 112 18 YEARS N/A ONC ENDO: THYROID

NCT01913054 JIANGSU NHWA DRUG 1. PLANNING 4 2450 45 YEARS 75 YEARS GI DISEASE

NCT01915914 GSK DRUG 1. PLANNING 4 120 1 YEAR 18 YEARS DERM SKIN DISEASE

NCT01916200 GSK DRUG 1. PLANNING 4 256 18 YEARS 65 YEARS PSYCH DEPRESSION

NCT01916226 GSK DRUG 1. PLANNING 4 648 18 YEARS N/A ALLERGY RHINITIS

NCT01924182 MEDTRONIC DEVICE 1. PLANNING 4 222 18 YEARS N/A ANEST PAIN

Studies under planning, from Page 61

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 63)(Return to Page 1)

Page 63: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 63

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01930708 BIOGEN DRUG 1. PLANNING 4 1080 18 YEARS N/A NEUR MULTIPLE SCLEROSIS

NCT01936870 PFIZER DRUG 1. PLANNING 4 2000 N/A N/A UROLOGY INCONTINENCE

NCT01937325 THE ALFRED DRUG 1. PLANNING 4 20 16 YEARS 70 YEARS RESP CYSTIC FIBROSIS

NCT01943552 BOEHRINGER INGELHEIM

DRUG 1. PLANNING 4 192 50 YEARS 75 YEARS RESP COPD

NCT01948791 NOVARTIS DRUG 1. PLANNING 4 186 50 YEARS 85 YEARS NEUR ALZHEIMER/DEMENT

NCT01957150 GSK DRUG 1. PLANNING 4 280 40 YEARS N/A RESP COPD

NCT01957215 GSK DRUG 1. PLANNING 4 270 18 YEARS 65 YEARS ORTH TENDO DISEASE

NCT01959516 NOVARTIS DRUG 1. PLANNING 4 120 40 YEARS N/A RESP COPD

NCT01959919 PFIZER DEVICE 1. PLANNING 4 200 18 YEARS 65 YEARS HEM HAEMOPHILIA A/B

NCT01964521 MOLNLYCKE DEVICE 1. PLANNING 4 30 18 YEARS N/A ENDO DIABETES FOOT

NCT01977807 TECHNOLAS PERFECT

DEVICE 1. PLANNING 4 100 18 YEARS 85 YEARS OPHTHAL MYOPIA

NCT01981473 PFIZER OTHER 1. PLANNING 4 600 18 YEARS N/A RHEUM ARTHRITIS/GOUT

NCT01990534 MILLENNIUM DRUG 1. PLANNING 4 60 18 YEARS N/A ONC HEM: LYMPHOMA

NCT01728103 GEN-PROBE DEVICE 1. PLANNING NA 2100 16 YEARS N/A INFECT CHLAMYDIA

NCT01728714 ASTRAZENECA 1. PLANNING NA 250 18 YEARS N/A ENDO DIABETES

NCT01741025 SI-BONE DEVICE 1. PLANNING NA 100 21 YEARS 70 YEARS ORTH JOINT DISEASE

NCT01751139 GSK PROCEDURE 1. PLANNING NA 15006

MONTHS N/A INFECT DENGUE

NCT01772225 GSK OTHER 1. PLANNING NA 900 18 YEARS N/A ONC RESP: LUNG

NCT01777958 HOFFMANN-LA ROCHE

1. PLANNING NA 478 18 YEARS N/A ONC BREAST

NCT01793324 ASTRAZENECA 1. PLANNING NA 600 18 YEARS N/A PSYCH SCHIZOPHRENIA

NCT01795326 ASTRAZENECA 1. PLANNING NA 800 N/A N/A PSYCH SCHIZOPHRENIA

NCT01802788 ST JUDE DEVICE 1. PLANNING NA 1050 18 YEARS N/A CARDIO VALVE

NCT01818388 ZOLL CIRCULATION

DEVICE 1. PLANNING NA 50 18 YEARS N/A CARDIO HEART ARREST/DEATH

NCT01818947 ASTRAZENECA 1. PLANNING NA 200 18 YEARS N/A ONC RESP: LUNG

NCT01824563 ADVANCED BIONICS

OTHER 1. PLANNING NA 120 18 YEARS N/A ENT HEARING LOSS

NCT01829152 VERIZON DEVICE 1. PLANNING NA 100 18 YEARS N/A CARDIO CARDIO-MYOP/FAILURE

NCT01832714 NEURO KINETICS

1. PLANNING NA 180 19 YEARS 45 YEARS NEUR HEAD INJURY/TRAUMA

Studies under planning, from Page 62

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 64)(Return to Page 1)

Page 64: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 64

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01834222 PFIZER BIOLOGICAL 1. PLANNING NA 600 50 YEARS N/A INFECT PNEUMOCOCCAL

NCT01838980 MOTUS GI DEVICE 1. PLANNING NA 50 50 YEARS 69 YEARS GI COLON CLEANSING

NCT01845103 CARDIOGEN-ESIS

1. PLANNING NA 22 18 YEARS N/A CARDIO ANGINA

NCT01850199 PARC TAULI OTHER 1. PLANNING NA 20 18 YEARS 46 YEARS ENDO DIABETES

NCT01851772 XOFT DEVICE 1. PLANNING NA 5 N/A N/A ONC O&G: CERVIX

NCT01859572 RENEURON 1. PLANNING NA 200 18 YEARS N/A CARDIO STROKE

NCT01860092 SECOND SIGHT 1. PLANNING NA 53 25 YEARS N/A OPHTHAL RETINITIS

NCT01866475 VIDACARE DEVICE 1. PLANNING NA 120 21 YEARS N/A CARDIO DISEASE

NCT01869101 TETHYS 1. PLANNING NA 560 18 YEARS N/A ENDO DIABETES

NCT01885572 PFM DEVICE 1. PLANNING NA 260 18 YEARS 75 YEARS DERM BREAST RECONSTR/IMPLANT

NCT01885585 BMS DRUG 1. PLANNING NA 3000 19 YEARS N/A CARDIO THROMB/COAG

NCT01885598 BMS DRUG 1. PLANNING NA 3000 19 YEARS N/A CARDIO ARRHYT/FIBRILL

NCT01887639 ASTRAZENECA 1. PLANNING NA 200 18 YEARS 75 YEARS PSYCH DEPRESSION

NCT01890447 GSK OTHER 1. PLANNING NA 700 18 YEARS N/A INFECT PERTUSSIS

NCT01896089 BIOLOGICTX 1. PLANNING NA 100 18 YEARS N/A UROLOGY KIDNEY TRANSPLANT

NCT01899573 GUIDED DELIVERY DEVICE 1. PLANNING NA 20 18 YEARS N/A CARDIO VALVE

NCT01907048 BAYER BEHAVIORAL 1. PLANNING NA 4000 18 YEARS N/A CARDIO THROMB/COAG

NCT01907828 ST JUDE DEVICE 1. PLANNING NA 100 18 YEARS N/A CARDIO ARRHYT/FIBRILL

NCT01911078 ST JUDE PROCEDURE 1. PLANNING NA 60 18 YEARS 80 YEARS ENDO METABOLIC SYNDROME

NCT01913613 DC DEVICE DEVICE 1. PLANNING NA MISS-ING

40 YEARS N/A CARDIO CARDIO-MYOP/FAILURE

NCT01915888 GSK OTHER 1. PLANNING NA 1 N/A 5 YEARS INFECT ENTERITIS

NCT01917968 BOSTON SCIENTIFIC

DEVICE 1. PLANNING NA 414 18 YEARS N/A GI PELVIC PROLAPSE

NCT01919320 SYNCARDIA DEVICE 1. PLANNING NA 302 N/A N/A CARDIO CARDIO-MYOP/FAILURE

NCT01925794 CELONOVA DEVICE 1. PLANNING NA 296 18 YEARS N/A CARDIO CORO-NARY/ISCHEMIC

NCT01934452 PFIZER DRUG 1. PLANNING NA 120 18 YEARS 80 YEARS ONC UROLOGY: KIDNEY

NCT01936636 GALENA DRUG 1. PLANNING NA 2500 18 YEARS N/A OTHER QUALITY OF LIFE

NCT01939249 BIOTRONIK DEVICE 1. PLANNING NA 585 18 YEARS 80 YEARS CARDIO CORO-NARY/ISCHEMIC

Studies under planning, from Page 63

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 65)(Return to Page 1)

Page 65: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier WeeklyDec. 12, 2013 page 65

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01940328 ECHOSENSE DEVICE 1. PLANNING NA 150 18 YEARS N/A RESP INSUF/ FAILURE

NCT01942200 ONKOVIS 1. PLANNING NA 350 N/A N/A ONC SOLID TUMOR/CANCER

NCT01944618 BMS DRUG 1. PLANNING NA 5000 18 YEARS 75 YEARS ENDO DIABETES

NCT01945580 BOSTON SCIENTIFIC

PROCEDURE 1. PLANNING NA 454 18 YEARS N/A GI PELVIC PROLAPSE

NCT01949779 STRYKER DEVICE 1. PLANNING NA 70 18 YEARS 80 YEARS NEUR NEUROPATHY

NCT01952392 ASTRAZENECA 1. PLANNING NA 3750 18 YEARS N/A CARDIO CORO-NARY/ISCHEMIC

NCT01953822 GSK OTHER 1. PLANNING NA 260000 9 YEARS 25 YEARS IMMUNE AUTOIMMUNE

NCT01955681 ASTRAZENECA 1. PLANNING NA 200 20 YEARS N/A ONC RESP: LUNG

NCT01959555 NOVO NORDISK OTHER 1. PLANNING NA 2500 N/A N/A CARDIO THROMB/COAG

NCT01959867 TEI DEVICE 1. PLANNING NA 160 18 YEARS N/A ONC BREAST

NCT01960491 CARAG DEVICE 1. PLANNING NA 10 18 YEARS N/A CARDIO HEART CONGENITAL

NCT01962051 ST JUDE DEVICE 1. PLANNING NA 100 18 YEARS N/A CARDIO ARRHYT/FIBRILL

NCT01962558 MICROTRANS-PONDER

DEVICE 1. PLANNING NA 30 22 YEARS 65 YEARS ENT TINNITUS

NCT01963650 SHIRE OTHER 1. PLANNING NA 30 N/A 12 YEARS NEUR LEUKODYSTROPHY

NCT01970709 RENAISSANCE 1. PLANNING NA 250000 18 YEARS N/A HEALTHY/PHARM

NCT01972867 ANGIODYNAMICS DEVICE 1. PLANNING NA 6 50 YEARS 70 YEARS ONC UROLOGY: PROSTATE

NCT01974271 HOFFMANN-LA ROCHE

1. PLANNING NA 640 18 YEARS N/A HEM ANEMIA

NCT01974752 ASTRAZENECA DRUG 1. PLANNING NA 128 18 YEARS N/A ONC METASTATIC

NCT01976299 OSPREY DEVICE 1. PLANNING NA 700 18 YEARS N/A UROLOGY KIDNEY FAILURE

NCT01976793 ASTRAZENECA 1. PLANNING NA 450 18 YEARS 65 YEARS PSYCH DEPRESSION

NCT01977534 ABBOTT DEVICE 1. PLANNING NA 1000 18 YEARS N/A CARDIO CORO-NARY/ISCHEMIC

NCT01978223 GSK PROCEDURE 1. PLANNING NA 150012

WEEKS 5 YEARS INFECT ENTERITIS

NCT01983293 ST JUDE OTHER 1. PLANNING NA 250 18 YEARS N/A CARDIO CARDIO-MYOP/FAILURE

NCT01984346 NCONTACT DEVICE 1. PLANNING NA 153 18 YEARS 80 YEARS CARDIO ARRHYT/FIBRILL

NCT01985230 MAINSTAY DEVICE 1. PLANNING NA 96 21 YEARS 65 YEARS ORTH BACK PAIN

NCT01990040 NPS 1. PLANNING NA 1310 N/A N/A GI SMALL BOWEL

NCT01991470 MEDTRONIC DEVICE 1. PLANNING NA 150 2 YEARS 18 YEARS ENDO DIABETES

Studies under planning, from Page 64

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See Studies under planning, Page 66)(Return to Page 1)

Page 66: INsIde thIs Issue · 2013-12-13 · cardio cardio-myop/failure nct02004262 aduro biological 1. planning 2 240 18 years n/a onc gi: pancreas nct02004288 biogaia dietary sup. 1. planning

CliniCal Trial Magnifier Weekly Dec. 12, 2013page 66

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT00811993 HOFFMANN-LA ROCHE

DRUG 7. TERMINATED 1 10418

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT00985374 HOFFMANN-LA ROCHE

DRUG 7. TERMINATED 1 1118

YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01721902 MILTENYI DEVICE 7. TERMINATED 1 2318

YEARS N/A

CARDIO CORONARY/ISCHEMIC

NCT01134991 FOAMIX DRUG 7. TERMINATED 2 2118

YEARS N/A DERM ROSACEA

NCT01235741 BMS DRUG 7. TERMINATED 2 21318

YEARS 65

YEARS ENDO OBESITY

NCT01370876 NANG KUANG DRUG 7. TERMINATED 2 4620

YEARS 75

YEARS ONC ENT: NPC

NCT01900795 PURDUE DRUG 7. TERMINATED 2 11418

YEARS 45

YEARS SURG COMPLICATION

NCT01853436 LIFECELL DEVICE 7. TERMINATED 4 6018

YEARS N/A ONC BREAST

NCT01478074 ALTOR DRUG 8. WITHDRAWN 1 0 2 YEARS 59

YEARS ONC HEM: LEUKEMIA

NCT01452295 VITAL THER. DRUG 8. WITHDRAWN 2 018

YEARS 65

YEARS GI LIVER FAILURE

NCT01762852 GSK DRUG 8. WITHDRAWN 2 018

YEARS 75

YEARS UROLOGY KIDNEY NEPHRITIS

NCT01599494 MERCK DRUG 8. WITHDRAWN 3 018

YEARS 42

YEARS O&G INFERTILITY

STuDieS eNDeD or HalTeD

This table lists studies that were terminated, suspended or withdrawn in the past week.

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

Clinical Trial Magnifier Limited: Managing Director, Johan PE Karlberg fDanews: president, Cynthia Carter; Content Director: Dan Landrigan; executive editor: Meg BryantCopyright © 2013 by Clinical Trial Magnifier. All rights reserved. Clinical Trial Magnifier Weekly is produced jointly by Clinical Trial Magni-fier Limited, which is responsible for the content, and FDAnews, which is responsible for production and distribution. Clinical Trial Magni-fier Weekly (ISSN 2306-8388) monitors all the essential changes made in the U.S. trial registry for industry-sponsored clinical studies. It is published weekly, 52 issues. Price for nonprofit, academic, government, hospital, and study site subscribers, $697. Price for for-profit, in-dustry, and clinical research organizations, $1,297. For site license pricing, contact Nelly Valentin, [email protected]. Photocopying or reproducing in any form, including electronic or facsimile transmission, scanning or electronic storage is a violation of federal copyright law and is strictly prohibited without the publisher’s express written permission.

300 N. Washington St., Suite 200 • Falls Church, VA 22046-3431 • Phone: (888) 838-5578 • +1 (703) 538-7600 • Fax: +1 (703) 538-7676www.fdanews.com

Customer Service: Kim Williams editorial: Dan Landrigan ad Sales: Jim Desborough Content Sales: Nelly Valentin(888) 838-5578 • +1 (703) 538-7600 (703) 538-7649 (703) 538-7647 (703) [email protected] [email protected] [email protected] [email protected]

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe DiSeaSe/

CoNDiTioN

NCT01992497 NESTLE DIETARY SUP. 1. PLANNING NA 740 N/A 24 HOURS INFECT ENTERITIS

NCT01993862 ST JUDE OTHER 1. PLANNING NA 600 18 YEARS N/A CARDIO CARDIO-MYOP/FAILURE

NCT01998412 ALIMERA 1. PLANNING NA 800 N/A N/A HEALTHY/PHARM

NCT02000115 ST JUDE DEVICE 1. PLANNING NA 1610 21 YEARS N/A CARDIO VALVE

Studies under planning, from Page 65